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FOREWORD

In an attempt to make this dissertation a continuous and complete
work, some portions of research were omitted. This Includes
investigation of structure-function relationships of the enterotoxin from
Clostridium oerfrinaens. performed under the guidance of Dr. E. W.
Blakeney, which led to one publication (Salinovich, 0 . , (lattice, W .f and
Blakeney, E. W. 1962. Effects of temperature, pH, and detergents on the
molecular conformation of the enterotoxin of Clostridium perfrinaens.
Biochim. Biophys. Acta 707: 147-153). In addition, work leading to the
development of a novel peptide mapping technique not used directly in my
dissertation research was also not included (Salinovich, 0 . and
Montelaro, R. C. 1986. Reversible staining and peptide mapping of
proteins transferred to nitrocellulose after separation by
SDS-polyacrylamide gel electrophoresis. Anal. Biochem., in press).
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ABSTRACT

Four isolates of equine infectious anemia virus (EIAV) recovered
weeks apart from a single experimentally infected Shetland pony (Orrego,
1983) were examined in both antigenic and structural analyses to
investigate variation occurring during persistent Infection. These four
isolates were shown to be antigenically distinct in both serum
neutralization assays and in immunoblot analysis with either a polyclonal
equine reference antiserum or a panel of virus-specific monoclonal
antibodies. Two-dimensional mapping of tryptic peptides of viral
components from these isolates revealed that both gp90 and gp45 undergo
structural variation during virus replication in a single animal, but that
no such structural variation occurs in the internal proteins p26, p i5, or
p9. Through the use of a novel two-dimensional mapping technique
developed for analysis of tryptic glycopeptides, it was demonstrated that
structural variation also occurs in the glycopeptides of both gp90 and gp45
during persistent infection.
A panel of nine EIAV Isolates recovered from two Shetland ponies
infected in parallel with the same EIAV inoculum were examined by the
same antigenic and structural analyses to investigate the extent of
variation possible. Although antigenic studies of these isolates were
limited, the nine EIAV isolates together with the prototype strain

ix

represent at least seven distinct serotypes. All ten EIAV strains were
shown to structurally distinct by virtue of peptide and glycopeptide
alterations in both gp90 and gp45. No pattern of evolution of variation was
evident by comparison of the nine isolates from the two parallel
Infections, indicating that a relatively large number of distinct EIAV
variants may be possible.
Hydropathic character and general conformation of the gp90 and gp45
polypeptides were accomplished by computer analysis of the amino acid
sequence of the envelope polyprotein, as predicted from the nucleic acid
sequence of the proviral env gene (Rushlow et a l., 1986). The results
predict that gp90 is a relatively hydrophilic, globular protein with 13
potential glycosylation sites evenly distributed throughout the molecule.
The gp45 polypeptide is relatively hydrophobic with four of five possible
glycosylation sites localized to the N-terminal region, and contains four
possible transmembrane regions. It appears from the conformational
analysis that an extensive region of P-sheet may exist at the c-terminus of
gpQO and the N-terminus of gp45, thus forming an area of Interchain
hydrogen bonding responsible for the close association of these two
molecules In the mature virton. By combining all predicted structural
features, it was possible to construct a model of the gp90/gp45 complex.
This model may serve as a reference for the production of effective
vaccination protocols against this economically Important virus.

x

CHAPTER 1
INTRODUCTION

EQUINE INFECTIOUS ANEMIA: THE DISEASE
Equine infectious anemia (EIA) is an acute hemolytic disease caused by
a nononcogenic retrovirus and occurs worldwide in members of the family
equidae (Charman et a l . , 1976; Cheevers et a l . , 1977; Issel and Coggins,
1979). Although one of the first diseases shown to be caused by a virus
(Vallee and Carre, 1904), very little was known about the molecular
characteristics of the virus or the disease until the last five to ten years.
In the United States, Louisiana has the highest reported incidence of the
disease. About 5% of the horses sampled between 1976 and 1981 in this
state tested positive for EIA, although it is believed that in some areas of
Louisiana the infected population may be as great as 30 to 40% (Foil and
Issel, 1982).
Clinical Symptoms
EIA is unique among retroviral-induced diseases because of its
episodic nature (Crawford et a l . , 1978; Issel and Coggins, 1979; Orrego et
a l . , 1982). After infection, the disease occurs in unpredictable bursts of
clinical symptoms and plasma viremia separated by weeks or months,
between which the animal may be clinically normal. Individual responses
to infection by natural or artificial routes are variable and may depend in
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part on host resistance factors, relative virulence of the infecting virus,
or environmental stresses. Infected horses may exhibit acute, chronic,
or inapparent stages of the disease, as depicted graphically In Figure 1.
Acute EIA - - This form of the disease Is usually associated with the

„

first exposure to the virus and results from massive virus replication in
infected macrophages and subsequent cell destruction. Clinical symptoms
include hemorrhages and fever. Anemia and edema are not 3 een in this
stage of the disease.
Chronic EIA — Animals with chronic EIA exhibit characteristic episodic
bursts of clinical symptoms, such as weight loss, anemia, lethargy,
subcutaneous edema, leukopenia, and central nervous system
depression, as well as fever and hemorrhages (Orrego et a l . , 1982).
Inapparent EIA — Animals in this stage of the disease exhibit no
clinical symptoms, and are apparently healthy. However, they harbor the
virus for life, and although asymptomatic, virus or viral products can be
detected in the blood of such animals (Kemen and Coggins, 1972; Issel et
a l., 1982).
infected animals may exhibit one or more of these disease stages.
Some suffer chronic EIA, with episodes of increasing severity, until
finally succumbing to the disease. In most cases animals experience
several recurring disease episodes, after which they become inapparently
infected carriers. Such animals may remain asymptomatic for the rest of
their natural lives, or chronic EIA may return after such environmental
stresses as overwork or other disease infections. Recurring episodes

INAPPARENT

Temperature

CHRONIC

TIME

STRESS

Figure 1 . Schematic representation of the different disease stages
observed in animals with equine infectious anemia.
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may also be induced in inapparently infected animals by injection with
immunosuppressent drugs (Orrego et a l . f 1982). Occasionally, affected
horses undergo only the initial febrile attack, and remain asymptomatic
for life. Since symptoms during initial infection are sometimes rather
mild in these cases, the disease may be overlooked, and these animals
become serious threats to uninfected animals as unidentified carriers of
EIA.
Transmission
Transmission of EIA is mainly horizontal and only rarely vertical.
Horizontal transmission is commonly the result of hematophagous
arthropod insects, feeding on horse blood (issel and Coggins, 1979; Foil
and Issel, 1982; Williams et a l., 1981), or from the use of contaminated
instruments or syringes, thus transferring infective blood or blood
products (Issel and Coggins, 1979). The potential for transmission from
an infected donor appears to be higher in the presence of clinical signs
than in the absence and seems to correlate directly with the level of free
virus in the donor's blood and tissues. The virus can apparently cross the
placental barrier and cause fetal infection, although more than 75% of the
foals born to infected mares can be raised free of EIA (Kemen and
Coggins, 1972; Foil and Issel, 1982).
Diagnosis and Control
EIA can be diagnosed on the basis of its characteristic clinical signs,
hematology, or pathology. Clinical signs, however, are not always
definitive, therefore specific laboratory tests are necessary and
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important to the diagnosis of this disease. Such tests usually involve the
detection of virus or EIA specific antibody in the suspected animal.
One such test demonstrating the presence of virus in the blood of an
animal is the horse inoculation test, which 1s performed by injecting its
blood into a susceptible horse. Development of disease in the recipient
animal indicates the presence of virus in the donor horse. In addition to
being expensive, time consuming, and wasteful, it is often difficult to
Interpret the clinical signs of the recipient.
Several serological tests have been developed for diagnosis and
research of EIA infection. These include the complement fixation test
(Kono and Kabayashi, 1966), the serum neutralization test, and the agar
gel Immunodiffusion (AGID) test (Roth et a l., 1971; Coggins et a l., 1972).
The AGID test, which is widely used in the diagnosis of EIA, allows for
reliable and sensitive detection of EIA specific antibody in the serum of a
suspected animal. Although a correlation between precipitating antibody
and EIA viremia has been demonstrated (Coggins et a l., 1972), the AGID
test, as with any serological test to detect antibody, cannot detect the
phase of infection prior to antibody production nor distinguish whether or
not there is active replication of virus in the animal.
More sensitive serological tests, such as Immunofluorescence
(Crawford et a l . , 1971), radioimmunoassay (Coggins e t a l . , 1978), and
enzyme linked immunoassay (Shane et a l., 1984), have been developed to
detect EIAV antigen or antibody. These tests can aid in the diagnosis of
those cases in which AGID titers are extremely low.
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Since prevention or treatment of EIA has not yet been successful,
efforts to control this disease have mainly involved screening for EIA and
subsequent regulation of transportation and housing of EIA positive
animals.
EQUINE INFECTIOUS ANEMIA VIRUS: THE CAUSATIVE AGENT
Equine infectious anemia virus (EIAV) is a member of the retrovirus
family of RNA viruses. These viruses have been isolated from a diverse
group of animals and are capable of producing a wide array of oncogenic,
nononcogenic, and progressive diseases. Characteristics common to all
retroviruses include the nature of their genomes, their mechanism of cell
entry, their structure, and their mode of replication through a DNA
intermediate. This last attribute distinguishes this virus family from
other RNA viruses, such that any virus utilizing a virus-coded
RNA-directed DNA polymerase for replication of its genome is included in
the retrovirus family. Common taxonomic features of the family
Retroviridae are summarized in Table I.
EIAV has been shown to exhibit many of the properties common to
retroviruses. Virus particles have a buoyant density of 1.15 - 1.16 g/ml
at 20°C, and a general spherical shape of 80 - 120 nm diameter (Charman
e t a l., 1976; Parekh et a l . , 1980). These particles possess a central
core or capsid containing 8 ribonucleoprotein complex. The virus
contains a 60 - 70S RNA genome, composed of two identical single
stranded subunits of 34S and the virus-derived reverse transcriptase
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Table I .

Taxonomic characteristics common to members of the family
Retroviridae.®

Morphology

Spherical enveloped virions(8 0 - 120 nm in diameter),
variable surface projections (8 nm), icosahedral or
cubic capsid containing a ribonucleoprotein complex

Physicochemical

Density 1.16 to 1.18g/m l in sucrose, 1.16 to 1.21

properties

g/ml in cesium chloride, sensitive to lipid solvents,
detergents, and heat Inactivation (56°C, 30 m1n),
highly resistant to UV and X-radiation

Nucleic acid

Linear posltive-sense single-stranded RNA (60 to 70 S)
composed of 2 identical subunits (30 to 35 S ), 5‘ cap
(M7 G^ppp^NpNp), polyadenylated 3* end, 1% by weight

Protein*

About 60% by weight; gag, internal structural proteins
(4 to 5); pol%reverse transcriptase and protease (1 to
2 ); env> envelope proteins (1 to 2 )

Lipid

About 35% by weight, derived from cell membrane

Carbohydrates

About 4% by weight, associated predominantly with env
proteins

Sfrom Teich (1982), and Bharat Parekh, Ph.D. dissertation, Louisiana
State University, 1983
*The figures in brackets indicate the number of resultant polypeptides.
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(Charman et a l . , 1976; Cheevers et a l . , 1978). EIAV is sensitive to ether
and detergents, or any reagents which disrupt the lipid envelope.
V1ru 3 Morphology
The general structure of retroviruses has been investigated by
electron microscopy (Bernhard et a l . , 1958; Gross, 1970; Vigier, 1970).
Most retroviruses are roughly spherical, and about 100 nm in diameter.
They consist of an outer lipid membrane, which is derived from the host
cell, surrounding a core of either icosahedral or cubic symmetry. The
envelope possesses numerous spikes and knobs, consisting of
glycosylated proteins (Rifkin and Compans, 1971). Retroviruses can be
divided into four morphologic categories, according to minor differences
revealed by electron microscopy: type-A, type-B, type-C, andtype-D
particles (Bernhard, 1960; Sarkar et a l . , 1972; Fine and Schochetman,
1978). These differences are associated with the location of the inner
core within the envelope, presence or absence of visible Intracellular or
extracellular viral particles, and appearance changes during the process
of budding from the host cell membrane.
Electron micrographic studies of EIAV revealed spherical particles of
8 0 - 120 nm diameter, with rod- or cube-shaped electron-dense
nucleoids, 40 - 60 nm in length or diameter (Weiland et a l . , 1977; Teich,
1982). Thin surface projections or spike-and-knob structures were
observed on the membrane surface, and in some cases an inner shell or
coat was also observed. EIAV buds from the host cell plasma membrane
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following the appearance of cresent-shaped or semicircular cores
beneath the membrane. The electron-lucent region between the core and
the lipid bilayer that is typical of type-C retroviruses was not evident in
mature virions. Thus EIAV most closely resembles vlsna virus or human,
T-cell lymphotropic virus type ill/lymphadenopathy virus (HTLV-111/LAV)
morphologically, and is distinct from type B, C, or D retroviruses (Gonda
et a l., 1985).
Virus Replication
As mentioned above, one of the unifying characteristics of
retroviruses is the mode of replication. The simplest representation of
this replication can be given as
RNA -* DNA-+ RNA (-> protein)
where the first step Is performed by a virus-coded, RNA-dlrected DNA
polymerase which is carried in the infectious virion, and the subsequent
step(s) performed by host enzymes.
Retroviruses usually establish themselves stably into the cells they
infect, and this is accomplished by covalent integration of a double
stranded retroviral DNA copy into the host cell’s chromosomal DNA.
Several intermediate DNA molecules 8 re synthesized from viral RNA,
leading to the integrated provirus. A schematic view of the major events
In this replication cycle are depicted in Figure 2 (Varmus and Swanstrom,
1982). Transcription of provirsl DNA results in at least two mRNA
species, a larger species serving as message for translation of the gag
and pol genes, and a smaller species coding for the env genes. The
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Figure 2 .

A simplified schematic representation of replication and

integration of the retrovirus genome. 1. Viral RNA*. Rg»R3 “ 5’ and 3'
terminal repeats; 1)5,113 = 5' and 3' untranslated regions; PB = primer
binding site; 6 , P, and E ■ gag, pol, and env genes, respectively. 2 and
3. cDNA and double stranded DNA synthesis. 4. Circular double stranded
viral DNA. 5. Integration of viral DNA into host genome. 6 .
Transcription of proviral DNA to yield mRNAs and viral RNAs.
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large RNA species is also the viral genome which is packaged into progeny
virus.
Stable integration of EIAV proviral DNA into the host cell genome has
been demonstrated in persistent nonlytlc infection of equine fibroblasts In
tissue culture (Crawford et a l . , 1978; Rice et a l . , 1978), as detected by
hybridization studies with cDNA synthesized from viral RNA. These studies
revealed an average of two to six complete DNA proviral sequences per
haplold genome. There was no detectable hybridization of EIAV cDNA with
normal horse DNA, indicating that it is not an endogenous virus of the
horse. In addition, no ElAV-related sequences were found in the DNA from
other Equus species or in a variety of other mammals, nor would EIAV
cDNA hybridize with a variety of other retroviruses.
Virus Polypeptides and Their Location
Studies involving identification of viral polypeptides by high resolution
sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE)
and guanidine hydrochloride gel filtration techniques have been performed
for many retroviruses, including EIAV (Montelaro et a l., 1978; Parekh et
a l., 1980; Montelaro et a 1., 1982). In addition, localization studies have
provided information about the organization of these polypeptides within
the virion. The results of these studies for the prototype-C mammaltan
retrovirus Friend murine leukemia virus (FLV) and the avian counterpart
Rous sarcoma virus (RSV) are given in Table II, along with the results
obtained for EIAV.
Surface labeling and careful digestion of intact virions revealed two
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Table I I . Structural components of avian and murine type-C
retroviruses, as well as EIAV

Virion polypeptides

Structural

Virion

Component

Structure

Avian

Murine

EIAV

gp85

gp7i

gp90

Knob

Envelope

gp35

p!5E

gp45

Spike

Envelope

pp19

pp!2

ppl5

Inner coat

Inner coat

p27

p30

p26

Core shell

Core

pi 5

p15C

p9

Core associated

Core

P1Z

pi 0

Pi 1

Nucleoproteln

Ribonucleoprotein
complex

Montelaro and Bolognesf (1980)
Montelaro et al. (1982)
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surface polypeptides associated with the lipid envelope, one or both of
which are glycosylated (Cheevers et a l., 1980; Mosser et a l., 1977;
Montelaro et a l . , 1982). These comprise the knob-and-splke structures
seen in electron micrographs, with the larger more hydrophilic
component (gp85, gp71, or gp90) forming the knob and the smaller more
hydrophobic component (gp35, p15E, or gp45) forming the spike which
may span the lipid btlayer. These two surface components may or may not
be linked covalently by disulfide bridges, depending on the particular
virus. No such disulfide bridges between the gp90 and gp45 components of
EIAV appear to exist (Montelaro et a l . , 1982).
Analysis of subvlral particles derived by partial disruption of intact
virions demonstrated that the core structure seen in electron
micrographs consists mainly of the most abundant nonglycosylated
polypeptide of the virion (p27 for the avian case, p30 for the murine case,
and p26 for EIAV), and a smaller, highly basic polypeptide (Davis and
Rueckert, 1972; Schafer and Bolognesi, 1977; Montelaro et a l . , 1982).
These cores are of icosahedral symmetry in the murine retrovirus, and
are cube-shaped in EIAV. Further disruption of the cores releases a
rlbonucleoproteln complex consisting of the RNA genome and a highly basic
polypeptide, along with the reverse transcriptase (Bolognesi, 1974; Davis
andRueckert, 1972; Montelaro et a l . , 1982). The basic component in the
avian virus is p12, in the murine virus it is p10, and in EIAV it is pi 1.
Electron microscopic studies of these retroviruses demonstrated a
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thin layer just beneath the viral envelope, designated the inner coat. The
major phosphoprotein found in these retroviruses was not present in the
core structure and was not detectable at the virus surface (Schafer and
Bolognesi, 1977; Montelaro et a l . , 1982). In the avian virus, the pp19
component could be crosslinked to gp35 in intact virions treated with
reversible crosslinking reagents. Thus these phosphoproteins (pp19 in
the avian virus, pp12inthe murine virus, and pp15 in EIAV) are thought to
comprise this inner coat.
With the information from both electron microscopy and the
localization experiments, a tentative model of the intact EIAV virion has
been proposed, as shown in Figure 3 (Montelaro et a l . , 1982). The gp90
and gp45 components, coded by the env gene of viral RNA, comprise the
knob and spike structures, respectively, found on the virion surface. A
thin inner coat composed of the phosphoprotein ppl 5 is located just
beneath the lipid envelope, which is derived from the host cell membrane
during budding. The core shell Is composed of the major nonglycosylated
polypeptide p26. This core shell surrounds the positive-sense RNA
genome and its closely associated basic polypeptide pi 1. The reverse
transcriptase i3 also associated with this ribonucleoprotein complex. The
last remaining nonglycosylated polypeptide of EIAV, p9, has not been
definitively located, but is shown as associated with the core structure
since it cannot be found either at the virion surface or in association with
the ribonucleoprotein complex.

gp90

gp45

Figure 3 .

Proposed structure and organization of EIAV.
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CLASSIFICATION OF EIAV AS A LENTIVIRUS
Subfamilies of Retroviridae
The retrovirus family has been further divided into three subfamilies:
oncovirlnae, lentlvirinae, and spumavtrinae. The criteria for
classification is based in part on cross-reactivitiy of the group-specific
major antigen within a subfamily, and in part on the characteristics of the
disease the virus induces in infected animals.
Oncovirinae includes the oncogenic and serologically related
nononcogenic retroviruses, non-infectious replication-defective
oncoviruses, snd those retroviruses which are difficult to classify.
Members of this subfamily include the murine leukemia and sarcoma
viruses, the avian leukemia and sarcoma viruses, and bovine leukemia
virus. Human T-cell leukemia virus types I and II (HTLV-I and HTLV-II)
have also been tentatively placed in this group (Poiesz et a l . , 1980;
Kalyanaraman et a l . , 1982).
Spumaviruses, or foamy viruses, have been Isolated from a number of
mammalian species, and establish persistent infections without evidence
of pathogenesis. These viruses induce a characteristic foamy
degeneration of infected cells in tissue culture after a few weeks.
Members of this subfamily include simian foamy virus (Rabin et a l. , 1976)
and bovine syncytial virus (Malmquist et a l . , 1969).
Lentiviruses cause slow, nononcogenic infections characterized by a
prolonged incubation period and a protracted symptomatic disease phase.
Originally, classification of a virus in this group was based more heavily
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on the nature of the Induced disease than on group-specific antigen
cross-reactivity. Most recently, with the advent of efficient molecular
cloning and nucleic acid sequencing technology, classification of a
retrovirus as either an oncovirus or lentivirus has been greatly aided by
determination of genomic organization (Sonigo et a l . , 1985; Gonda et a l . ,
1985). Members of this group include visna/maedi virus and progressive
pneumonia virus (PPV) of sheep, and caprine arthritis encephalitis virus
(CAEV) of goats. EIAV was first tentatively Included In this group because
of the chronic nature of its induced disease and virus morphology
(Charman et al. 1976;Parekh e t a l . , 1980; Montelaro et a l . , 198Z), but
no antigenic relatedness could be established between this virus and the
prototype lentivirus vlsna virus (Stowrlng et a l., 1979). Recent studies
of the genomic organization of EIAV has shown remarkable relatedness to
both visna virus and CAEV (Chiu et a l . , 1985; Stephens et a l . , 1986;
Rushlow et a l . , 1986), thus substantiating its classification as a
lentivirus. HTLV-lll/LAV, the causative agent of acquired immune
deficiency syndrome (AIDS), has been included in the lentivirus subfamily
because of its genomic organization and the progressive nature of the
disease (Gonda et a l . , 1985). In addition, it has been demonstrated that
the gag and pot genes of EIAV, visna virus, and HTLV-111 share a high
degree of sequence homology (Stephens, et a l . , 1986).
Classification of retroviruses by virtue of their genomic organization is
based on the presence of several small open reading frames in addition to
the gag%pot,\ and env genes in lentivlruses, which are absent in
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oncoviruses (Ratner et a l . , 1985; Sanchez-Pescador et a l . , 1985;
Wain-Hobson et a l . , 1985; Sonigo et a l . , 1985; Rushlow et a l . , 1986).
These short open reading frames (ORF's), which are usually located
between the po l and env genes and at the 3* end of the env gene, may
code for short polypeptides which are responsible for the distinct
pathogenesis of these viruses. In fact, it has been demonstrated that the
open reading frame between the po l and env genes of HTLV-lll/LAV is a
crucial part of the spliced gene responsible for the transactivating
activity of this virus (Sodroski et a l . , 1985; Ayra et a l . , 1985). A major
factor confirming the classifiaction of EIAV as a lentivirus is the presence
of these short ORF's, now a distinctive characteristic common to viruses
of this subfamily (Rushlow et a l . , 1986).
ANTIGENIC VARIATION: MECHANI5M FOR VIRAL PERSISTENCE?
One of the unique qualitites of EIAV is its ability to persist in the
infected animal in the face of an apparently competent immune response.
Kono et al. (1973) postulated that the virus isolate associated with each
disease episode in an animal was antigenically distinct, thus
circumventing the neutralizing antibody produced against previous virus
isolates. Evidence supporting this hypothesis was finally presented by
Montelaro et al. (1984a) In antigenic and structural studies of EIAV
isolates recovered months apart from different animals during back
passage of the virus in Shetland ponies. A panel of five isolates, obtained
from three different animals, were demonstrated to be antigenically
distinct in neutralization assays, in addition, structural differences were
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revealed in the major surface antigen gp90 from these isolates by
two-dimensional tryptic peptide mapping. This marked the first time that
antigenic variation and concurrent structural changes in the major EIAV
antigen had been demonstrated.
From these and earlier findings, it has been postulated that upon initial
infection by EIAV and subsequent plasma viremia, the infected animal
raises an apparently competent immune response and is able to clear
most of the virus (Figure 4 ). The animal then remains apparently healthy
until an antigenic variant of EIAV arises, causing a second burst of plasma
viremia and associated clinical symptoms. Antibody raised against the
original virus strain does not recognize the antigenic variant, so the
animal must mount a separate Immune response against It. This cycle
continues, until the animal dies or becomes an inapparent carrier.
Several major questions remain unanswered about this hypothesis.
First, where is the virus sequestered after the initial, apparently
competent Immune response? Also, how are the antigenic changes
introduced into the virus? What is the extent of this variation from one
strain to the next? How many different serotypes of EIAV are possible?
Very little is known about the exact target cells for replication of
EIAV. Early studies demonstrated that monocytes and macrophages are
the only known cells in horses in which EIAV replicates, and these cells
are the most readily permissive cells in vitro (McGuire et a l . , 1971;
Ushimi et a l., 1972). The closely related lentivirus, visna virus,
initially infects monocytes and macrophage precursors, but the virus is
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Schematic representation of the sequence of events in an

animal with chronic EIA.
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resticted at the level of transcription in these cells (Gendelman et a l . ,
1985). However, upon maturation of the infected monocytes to
macrophages, this transcriptional restriction is somehow removed, and
active replication of the virus takes place. A similar phenomenon may
occur during EIAV infection.
Recently, RNase Tj-resistant oligonucleotide mapping analysis of five
EIAV isolates demonstrated that distinct genomic changes had occurred In
these antigenic variants (Payne et a l . , 1984). Similar results have been
obtained for visna virus, where both genomic changes and structural
differences in the surface antigen gpl35 have been observed in distinct
antigenic variants (Scott et a l . , 1979; Clements et a l . , 1980). For both
of these lentlviruses, the relatively small number of genomic changes
observed were consistent with the occurrence of point mutations, possibly
arising during reverse transcription of the RNA genome. Recombinational
events, such as occur in the emergence of replication-defective highly
oncogenic sarcoma viruses (Elder et al. 1977a; Rosner a t a l., 1980),
would result in large differences in the RNA genomes. In addition, no
endogenous retroviral sequences have been found in horse chromosomal
DNA with which such recombination in EIAV could occur (Rice et a l . ,
1978). In the case of visna virus, the observed genomic changes In
isolates from the same animal appear to be cumulative (Clements et a l . ,
1982). In contrast, the genomic changes seen in EIAV isolates appear to
arise from the presence or absence of a specific subset of
oligonucleotides (Payne et a l . , 1984). Thus, although both viruses
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appear to undergo genomic variation by the introduction of point
mutations, the mechanism be which these mutations arise may by very
different.
The extent of variation possible between two successive 8ntfgenic
variants of EIAV has not yet been determined. Previous studies
demonstrated structural changes 1n the polypeptide portion of the surface
antigen gp90, but no information was gained about the contribution of
carbohydrate to this variation, or if variation was also present In the
second surface antigen gp45 (Montelaro et a l., 1984a). Since
approximately 10 to 15% of the host's immune response to gp90 is directed
toward the carbohydrate of this molecule, variation in glycosylation
should be investigated. Contribution of glycosylation to possible variation
in glycoprotein antigens has become increasingly important, since ft was
shown that a single amino acid change in the hemagglutinin (HA) of H5N2
avian influenza virus eliminated a single glycosylation site, thus
eliminating one of five mapped antigenic sites of this molecule (Kawaoka et
a l., 1984). This change is believed to be responsible for the
transformation of an avirulent influenza strain to a very virulent form.
Also, it has recently been shown that glycosylation can mask or protect
highly antigenic sites on the peptide backbone of some retroviral antigens
(Alexander and Elder, 1985), thus lowering the affinity of induced
antibody in the infected host. Thus, the relatively heavy glycosylation
seen in the major surface antigens of most lentiviruses may be
responsible in part for persistence of these viruses in the infected host
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(Sonigo et a l., 1985;Ratner, e t a l., 1985; Sanchez-Pescador et a l . , 1985;
Rushlow et a l., 1986).
The number of antigenically distinct serotypes of EIAV occurring in
natural Infections has not yet been determined. Previous Investigations „
have demonstrated at least five distinct serotypes produced by
experimental serial passage of the cell-adapted EIAV strain in Shetland
ponies (Orrego et a l., 1982; Montelaro et a l., 1984a; Payne et a l., 1984).
An estimation of the number of Infection-competent serotypes and the
extent of structural variation between these serotypes is necessary
before effective vaccine development can be accomplished. In the worst
situation, EIAV may resemble the rhinoviruses, which exist in at least 120
distinct serotypes (Cooper et a l., 1978), In which vaccine development
would be almost impossible.
RESEARCH OBJECTIVES
The main objective of the present research is to address some of the
unanswered questions of variation In EIAV. These objectives are listed
below, along with their relative significance.
1)

Can structural variation be observed in antigenic EIAV variants

recovered only weeks apart from a single animal? The extent of
structural variation necessary to produce an antigenically distinct strain
capable of circumventing the host's Immune defenses can be estimated.
Also, the method by which this structural variation arises in EIAV may be
examined.
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2) Is structural variation limited to gp90, or does the second surface
antigen gp45 also contribute to this variation? Examination of the gp45
component of EIAV isolates by two-dimensional tryptic peptide mapping
has been previously hampered by very high background and low yields of
this glycoprotein (Montelaro et a l . , 1984a). Thus it is not known whether
this second surface antigen also contributes to antigenic and structural
variation in EIAV.
3) What Is the contribution of glycosylation to antigenic and structural
variation in EIAV? The importance of glycosylation to antigenic properties
of glycoproteins is becoming increasingly evident, as discussed in the
previous section. It is therefore important to devise procedures whereby
the general glycosylation patterns of the two surface glycprotelns gp90
and gp45 from EIAV antigenic variants can be compared, thus determining
the contribution of glycosylation in EIAV variation.
4) How many serotypes of EIAV may exist, and what is the extent of
structural variation between these serotypes? Is there a predictable
pattern to the evolution of EIAV variants? Such information is vital to the
future development of successful vaccination protocols for control of this
economically important disease.
5) What structural features of the surface antigens gp90 and gp45 can
be determined by computer modeling of the proposed 8mino acid sequence
for these two components? Through this modeling, some region or
regions of these molecules may be determined as essential for infectivity
of EIAV, and thus may be used as targets for the production of synthetic
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vaccines.
The first three points were examined through structural analysis of the
polypeptide components of four EIAV isolates recovered four to eight
weeks apart from a single experimentally infected animal.
Two-dimensional tryptic peptide mapping was performed according to
established procedures (Elder et a l . , 1977b; Montelaro et a l . , 1984a) for
the three internal polypeptides p26, p i5, and p9, as well as the
glycoprotein antigen gp90. Methods for the Isolation of gp45 for
subsequent mapping were improved, such that it could be included in the
analysis. In addition, modifications to the two-dimensional mapping
procedure have been developed such that glycosylated peptides could be
examined.
Similar structural analysis was also performed on five additional EIAV
strains recovered from a parallel experimental infection, such that a
total of nine isolates (in addition to the cell-adapted strain) were
examined. The isolates recovered from the two parallel Infections were
compared to determine if any predictable pattern of variant emergence
could be identified. In this wsy, an estimation of the total variation
possible in EIAV was accomplished.
Finally, the amino acid sequence of the two surface antigens gp90 and
gp45, as predicted from proviral DNA sequencing (Rushlow et a l . , 1986),
was subjected to extensive computer modeling to determine important
structural features of these two glycoproteins. Location of glycosylation
sites, hydropathic character, and prediction of secondary structure by
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the procedures of Chou and Fasman (1974, 1978) were performed. This
information, coupled with known properties of analogous glycoproteins
from related lentiviruses, revealed important features which may be
necessary to the infectivity of EIAV.

CHAPTER 2
MATERIALS AND METHODS

Reagents
A list of chemicals used throughout this study, including sources of
supply and abbreviations, is given below.
acetic acid - J .T . Baker; acetonitrile (HPLC grade) - J.T. Baker; acid
fuschin - Sigma; cq-acid glycoprotein - Sigma; acrylamide - Biorad;
ammonium acetate - Sigma; ammonium bicarbonate - Sigma; ammonium
persulfate - Biorad; A utofluor- National Diagnostics Lab.;
1.4-bis-[2-(4-methyl-5-phenyloxazolyl)]-benzene (POPOP) - Packard;
bovine serum albumin (BSA) (fraction V, lyophilized) - Sigma;
bromophenol blue - Sigma; 1-butanol - J .T . Baker; cellulose-coated thin
layer plates (0.1 mm thickness; 20 x 20 cm) - E. Merck; chloramine-T Sigma; coomassie brilliant blue R-250 - Biorad; concanavalin
A/Sepharose 4B conjugate - Sigma; 7-deoxycholate (sodium salt)'(DOC) Sigma; diphenyl carbamyl chloride (DPCC)-treated trypsin - Sigma;
2.5-diphenyloxazole (PPO) - Packard! Eagle's minimal essential medium
(MEM) - GIBCO Lab.; ethanol (absolute) - Midwest Solvent Co.; ethylene
diamine tetraacetic acid (EDTA) - Sigma; ethylene glycol - J .T . Baker;
fetal bovine serum - GIBCO Lab.; fetuin (bovine) - Sigma;
[^Hl-glucosamine - NEN; glucose - Sigma; glycerol - Sigma; glycine -
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Sigma; guanidine hydrochloride - Sigma; N-2-hydroxyethylpiperizine-N'2-ethane sulfonic acid (HEPES) - Sigma; lentil lectin/Sepharose 4B
conjugate - Sigma; 2-mercaptoethanol - Sigma; 3-mercaptopropionic
acid - Sigma; methanol - J.T. Baker; N,N’-methylene blsacrylamide Biorad; a-methyl glucoside - Sigma; 2-methylnaphthalene - Aldrich;
neuraminidase (Type X from Clostridium oerfrinoens) - Sigma;
nitrocellulose membrane (0.45 pm ) - Millipore; nonidet P-40 (NP-40) Particle Data Lab., Inc.; orange 6 - Sigma; penlctllfn 6 - Pfizer; pyridine
- J .T . Baker; Sephadex G-25 (20-80 Mm) - Sigma;

sodium bicarbonate -

Sigma; sodium chloride - MCB; sodium dodecyl sulfate (SOS) - Biorad;
sodium hydroxide - MCB; sodium iodide - Sigma; I^ 5 |] _ 30C^um iodide ICN; sodium metablsulflte - MCB; sodium phosphate (dibasic) - Sigma;
sodium phosphate (monobasic) - Sigma; soybean trypsin inhibitor Sigma; streptomycin sulfate - Pfizer; N,N,N',N'-tetramethylene diamine
(TEMED) - Biorad; 2 ,6 ,1 0 ,14-tetramethyl pentadecane (Pristane) Aldrich; trichloroacetic acid (TCA) - J .T . Baker; trlfluoroacetlc acid
(TFA) - J .T . Baker; tris ( hydroxy methyl) aminoethane (Tris) - Sigma;
triton X-100 - Sigma; urea - Biorad; water (HPLC grade) - J .T . Baker;
xylenes - ASP.
Virus propagation and purification
The cell-adapted Wyoming strain of EIAV (Malmquist et a l . , 1973) wss
propagated in primary fetal equine kidney (FEK) cells maintained In
Eagle’s minimal essential medium (MEM) supplemented with 5 to 10% fetal
bovine serum, 25 mM HEPES buffer, 10 mM sodium bicarbonate, 100 Units
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of penicillin G per ml, and 100 jig streptomycin sulfate per ml (Amborskl
et a l., 1979). This cell-adapted strain will be referred to as prototype
EIAV. Persistently infected FEK cell3 were maintained as confluent
monolayers at 37°C In ro ller bottle cultures (850 cm2 ) containing 50 ml e
of medium. Under these conditions virus production continued for 6 to 8
weeks, until cell senescence.
Supernatant medium was harvested every 3 days for virus purification.
After removal of medium from the cultures, all subsequent steps were
performed at 4°C. The medium was first clarified of cellular debris by
centrifugation in a Sorvall GSA rotor at 9500 rpm (12,000 x g ) for 15 min
followed by 10- to 40-fold concentration using a Pellicon membrane filter
cassette system (nominal exclusion 106 daltons molecular weight)
(Millipore Corp., Bedford, Mass.) . Virus was recovered from the
concentrated medium by centrifugation through an underlayered 10 ml
cushion of 20% glycerol in Dulbecco's phosphate buffered saline (PBS-A) in
a Beckman type 19 rotor at 19,000 rpm (50,000 x g) for 2 hr. Pelleted
virus was suspended in PBS-A, pH 7 .4 , and sedimented to its equilibrium
density (1.18 g/m l) (Montelaro et a l . , 1982) by centrifugation on 30 ml
25 to 90% glycerol gradients in a Beckman SW-28 rotor at 28,000 rpm
(130,000 x g) for 4 hr. The virus band was withdrawn with a Pasteur
pipette, diluted with PBS-A to a total volume of 40 ml, and any remaining
glycerol W8S removed by pelleting the virus by centrifugation in a
Beckman SW-28 rotor at 28,000 rpm (130,000 x g) for 90 min. The final
virus pellet was suspended in 10 mM sodium phosphate buffer, pH 7 .2 , and
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stored at -80°C in 500 Ml aliquots.
Virus recovery was estimated as protein as determined by the Lowry
assay (Lowry et a l . , 1951). Using the above procedures, about 10 mg of
EIAV could be purified per week from 10 roller bottles of infected FEK
cells yielding one liter of tissue culture fluid (Montelaro et a l . , 1982).
EIAV Isolates
For biochemical and immunological comparisons, virus isolates were
produced by serial passage of the prototype strain of EIAV In Shetland
ponies (Orrego et a l . , 1982). The inoculum used in all serial passages
between animals consisted of plasma, rsther than purified virus, in order
to reproduce as closely 83 possible the conditions of natural Infection.
Recovered virus Isolates were designated by passage, pony number, and
isolate number. For example, isolate P I. M

represents virus recovered

from plasma of a first passage animal, two weeks after inoculation when
the animal became AGID test positive. Likewise, isolate P 2 .1-1
represents virus Isolated from plasma during the first disease episode in
a second passage animal. A total of 9 EIAV isolates were included in this
study, as well as the prototype strain: four consecutive isolates from the
third passage Animal *1 (P3.1-1 through P3-1—4) and five consecutive
Isolates from the third passage Animal #2 (P3.2-1 through P3.2-5)
(Figures 5 and 2 4 ).
Whenever possible, serum neutralization assays were performed
according to the virus dilution-constant serum method (Montelaro et a l . ,
1984a), using serum taken from the same animal as the recovered EIAV
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Fig ure S.

Inoculation scheme followed for the production of EIAV

Isolates in experimentally infected Shetland ponies.
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isolates. Serum neutralizing activity was expressed as a logjQ
neutralizing index, calculated as the difference In logjQ titer of the virus
with or without test serum. A neutralizing index of 1.5 or greater was
considered positive.
Production of Monoclonal Antibodies
All monoclonal antibodies used in this study were the generous gift of
K. A. Hussain andK. L. Schnorr, Department of Veterinary Microbiology
and Parasitology, Louisiana State University School of Veterinary
Medicine, Baton Rouge, Louisiana. Briefly, BALB/c mice were immunized
subcutaneously and intraperitoneally with 100 jig of lentil lectin-purified
EIAV glycoproteins (see below) from the prototype strain of EIAV in
Freund complete adjuvant. Mice were boosted on day 14 with antigen
preparations in Freund incomplete adjuvant, and again on days 28 and 88
with antigen in 10 mM sodium phosphate buffer, pH 7 .2 . Four days after
the final injection, spleens were removed and minced, and the cells were
fused with SP2/0 mouse myeloma cells, which lack hypoxanthlne-guanine
phosphoribosyltransferase activity (Groth and Schneidegger, 1980).
Hybridomas were selected on hypoxanthine-amlnopterin-thymidine (HAT)
medium (Groth and Schneidegger, 1980), and cloned by at least three
cycles of limiting dilution. Clones were screened for ElAV-speciflc
antibody secretion in a solid-phase enzyme-linked immunosorbent assay
technique using disrupted EIAV as antigen, as described previously (Shane
et a l . , 1964). In order to insure monoclonality, hybridomas exhibiting
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anti-ElAV activity were cloned through two more cycles of limiting dilution
before subsequent screening and amplification. Ascites fluids were
produced by intraperitoneal injection of 1 x 10® to 5 x 10® hybridoma cells
Into syngeneic mice which had been injected 10 days previously with 0 .5 ml
Pristane (Massey and Schochetman, 1981).
Radioactive Labeling of EIAV in Vivo
EIAV was labeled in vivo with [^H]-glucosamine using modifications of
previously described procedures (Parekh et a l . , 1980). Infected FEK
cells in 75 cm2 flasks were transferred to medium containing 1/I0th the
normal amount of glucose for 24 hr. [^Hl-glucosamine was then added to
the existing medium to a final concentration of 20 jiCi/m l. Medium was
harvested after 48 hr and clarified of cellular debris by centrifugation in
a Sorvall SS-34 rotor for 15 min at 12,000 rpm (13,000 x g ). Labeled
virus was pelleted by centrifugation in a Beckman SW-28 rotor at 28,000
rpm (130,000 x g) for 90 min. The virus pellet was suspended in PBS-A
and stored at -20°C. The label-containing medium was then sterilized by
filtration through a 0.45 jim sterile disposable filtration unit (Nalgene)
and returned to the infected FEK monolayers. The medium was harvested
a second time after an additional 48 hr, and labeled virus was isolated as
above. The two [3H]-labeled EIAV harvests were combined, and virus was
pelleted through an underlayered 1 ml cushion of 202 glycerol in PBS-A by
centrifugation in a Beckman SW -50.1 rotor at 45,000 rpm (190,000 x g)
for 1 hr. The virus pellet was suspended in 10 mM sodium phosphate
buffer, pH 7.2 and stored at -80°C. Using these procedures, 2 .0 x 10® to
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4.5 x 106 (jpjm 0f [3H]-gIucosamine-labeled EIAV could be generated from
5 flasks of infected FEK cells per labeling experiment.
Radioactive Labeling of EIAV Components in Vitro

a. I^5|]-iabeling of EIAV polypeptides using chloramine-T
Viral protein or glycoprotein components were radiolabeled with
125l using the chloramine-T procedure (Hunter, 1978). The following
solutions were prepared fresh in 100 mM sodium phosphate buffer, pH 7.4:
chloramine-T, 4 .0 mg/ml; sodium metabfsulfite, 2.5 mg/ml; and sodium
iodide, 10.0 mg/ml. A 25 - 50 jig sample of protein was placed in a 10 x
75 mm siliconized test tube, the total volume was brought to 200

jjlI

with

100 mM sodium phosphate buffer, pH 7 .4 , and 1 mCi [ ,2 5 l]-sodium iodide
(20 jil) was added. Reaction wss initiated by addition of 25 jil
chloramine-T. The reaction was allowed to proceed at 0°C for 3 min and
then terminated by the addition of 100 jil sodium metabisulfite. To
minimize noncovalent association of

to proteins, 200 jil of nonlabeled

sodium Iodide was added as carrier. Unreacted [ 125l]-sodium iodide was
separated from radioiodinated protein using a 10-ml column of Sephadex
G-25 prepared in a disposable pipette and eluted with 10 mM sodium
phosphate buffer, pH 7 .2 .
The activity of [ 125l]-1abeted protein was expressed as acid
precipitable counts. Duplicate 5 jil samples of the radioiodinated protein
were mixed with 100

jjlI

1 mg/ml B5A and counted using a Packard

Auto-gamma counter. Protein was precipitated by addition of 900 jxl cold
10% TCA and incubation at 0°C for 30 min. Samples were centrifuged in an
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Eppendorf microfuge for 10 min, and the supernatant fluid was discarded
to radioactive waste. The resultant protein pellets were counted to
determine acid precipitable activity.
b.

[^ l]-la b e lin g of EIAV polypeptides in polyacrylamide gel slices
In preparation for two-dimensional peptide mapping, certain EIAV

polypeptides were radioiodinated in polyacrylamide gel slices after
separation by SDS-PAGE (see below) according to modifications made to
the chloramine-T procedure (Greenwood et a l . , 1963; Hunter, 1978).
These modifications have been previously described (Elder et a l . , 1977b;
Montelaro et a l . , 1984a; Salinovich et a l . , 1986). Protein bands
visualized by coomassie blue staining corresponding to various
polypeptides of EIAV were excised from the get, and each slice was placed
in a perforated autoanalyzer cup and tightly capped. Gel slices were
washed for 6-8 hr in 25% aqueous 2-propanol with vigorous stirring to
remove coomassie blue. Gel slices were then transferred to 10%
methanol, and washed with vigorous stirring for 16-18 hr to remove SDS,
urea, and unpolymerized acrylamide. Gel slices were then transferred to
separate 10 x 75 mm siliconized test tubes and dried completely under
vacuum and mild heat. Before radioiodination, the following solutions
were prepared fresh in 500 mM sodium phosphate buffer, pH 7.5:
chloramine-T, 5 mg/ml; sodium metabisulfite, 1 mg/ml. Gel slices were
rehydrated for 10 min in 50 Ml 500 mM sodium phosphate buffer, pH 7 .5 ,
and 1 mCi I 125|]-sodium Iodide (20 p i) was added. Reaction was initiated
by the addition of 10 jjlI chloramine-T, and allowed to proceed for 30 min
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at room temperature. Reaction was stopped by the addition of 1 ml sodium
metabisulfite and incubation at room temperature for 15 min. The
reaction buffer was then discarded to radioactive waste, and the gel
slices were washed 10 times with 2 ml 10% methanol to remove unreacted
on the gel surface. Gel slices were transferred to separate
perforated autoanalyzer cups, tightly capped, and washed In 10% methanol
for 48 to 96 hr to remove any remaining unreacted *25) _
Sodium Dodecvl Sulfate Polvacrvlamide Gel Electrophoresis and Analysts
of Gels
The procedures used for sample preparation and sodium dodecyl
sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) in continuous
sodium phosphate buffers in both slab and cylindrical gels hsve been
previously described, as well as their analysis by staining,
autoradiography, and fractionation (Montelaro and Bolognesi, 1978;
Montelaro et a l . , 1982).
Gels used were 7.5% or 10% polyacrylamide containing 1 M urea, 0.1%
SDS, 0.1% TEMED, and 100 mM sodium phosphate buffer, pH 7 .2 . Gels
were polymerized by the addition of 5 ml 1% ammonium persulfate per 95
ml of acrylamide monomer. Cylindrical gels were 0.6 cm in diameter and
20 cm in length. Slab gels were 14 cm x 28 cm x 1.5 mm.
Electrophoresis buffer consisted of 100 mM sodium phosphate, pH 7.2,
with 0.1% SDS and 10 mM 3-mercaptopropionate. A ll gels underwent
electrophoresis for at lesst 1 hr at normal running conditions prior to
application of samples in order to eliminate any peroxides formed during
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the polymerization reaction.
Aqueous samples of radiolabeled or unlabeled proteins were brought to
a volume of 90 *il with 10 mM sodium phosphate, pH 7 .2 . Samples were
then made 1% in both SDS and 2-mercaptoethanol (in a final volume of 100
M l), and heated for 3 min in a boiling water bath. Sucrose was added to
give a final concentration of 20 to 30%, and 1 pi of 0.5% bromophenol blue
in 0.02 N sodium hydroxide was added to each sample as a tracking dye.
Samples were layered onto the gels followed by electrophoresis at 50 ma
per slab gel or at 8 ma per cylindrical gel for a total of 18-22 hr. Buffer
was circulated between the upper and lower chambers to prevent large pH
differences from developing during electrophoresis.
Nonradfoacttve proteins were visualized In slab gels by first staining In
0.25% coomassie brilliant blue in acetic acid: methanol: water
(46:227:227, v /v /v ) for 1 hr followed by complete destaining in acetic
acid: methanol: water (3:10:27, v /v /v ).
Radioactive proteins were visualized in slab gels by either
autoradiography or fluorography. Gels containing t '^^1]—labeled proteins
were fixed in destaining solution for 1 hr, dried under vacuum and mild
heat, and radiolabeled proteins were located by autoradiography using
Kodak X-Omat XRP-5 film . Gels containing [^Hl-labeled proteins were
fixed as above, then soaked for 1 hr in Autofluor before drying and
autofluorography (Shealv et a l. . 1980).
Cylindrical gels containing radiolabeled proteins were analyzed by
fractionation and counting. A highly-crosslinked plug of 40% acrylamide
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was cast on top of the gel after running, after which the gel was sliced in
uniform increments into flat-bottom vials using a Gilson automatic gel
fractionator (Gilson et a l., 1972). Gels containing M ^ lH a b e le d
proteins were fractionated Into distilled water, and fractions were
counted directly in a Packard Auto-gamma counter. Gels containing
I3H]-labeled proteins were fractionated into 50 mM ammonium
bicarbonate, and proteins were allowed to elute from the gel particles
overnight. Each fraction was then combined with 2 ml Tritosol (consisting
of 5.46 g PPO and 0.54 g P0P0P dissolved in 60% xylenes, 25 .7* Triton
X-100, 10.6% absolute ethanol, and 3.7% ethylene glycol; v /v /v /v ) and
counted in a Beckman scintillation counter.
Discontinuous SD5-PAGE
For separation of EIAV polypeptides in preparation for two-dimensional
peptide mapping, the discontinuous SDS-PAGE system developed by
Laemmli (1970) was used. Slab gels of either 10% or 15% acrylamide
(acrylamide: bisacrylamlde, 40:1) containing 0. t% SDS and 0.06% TEMED
were prepared in 375 mM Tris-HCl, pH 8 .8 . Gels were polymerized by the
addition of 5 ml 0.5% ammonium persulfate per 95 ml acrylamide
monomer. A 4% acrylamide stacking gel containing 0.1% SDS in 120 mM
Tris-HCl, pH 6.8 (3 to 4 cm in height) was overlayered onto the
polymerized running gel. Samples of 100 Ml were prepared in a disruption
buffer containing 625 mM Tris-HCl, 1% SDS, 10% glycerol, and 5%
2-mercaptoethanol, pH 6 .8 , and heated in a boiling water bath for 3 min
prior to loading. Slab gels were run at 25 ma for 18 to 22 hr.
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Electrophoresis buffer consisted of 25 mM Tris-HCl, 192 mM glycine, and
0.1% SDS, pH 8 .3 . Buffer was circulated between the upper and lower
chambers to prevent drastic changes in pH.
Proteins were visualized using procedures described above for
separation by continuous SDS-PAGE.
Electrotransfer of Polvoeotides from SDS-PAGE to Nitrocellulose
Membranes
Proteins were transferred to nitrocellulose sheets after separation by
SDS-PAGE according to previously described procedures (Burnette,
t981) . The polyacrylamide gel containing proteins to be transferred was
placed in direct contact with a nitrocellulose sheet which was previously
soaked for 10 mln In a transfer buffer consisting of 20 mM Tris-HCl, pH
8 .3 , and 150 mM glycine in 20% methanol. The gel and nitrocellulose
sheet were then sandwiched between two pieces of Whatman 3mm
chromatography paper and placed in a TE series Transfor apparatus
(Hoefer Scientific Instruments) such that the polyacrylamide gel faced the
cathode and the nitrocellulose sheet faced the anode. Electrotransfer of
proteins to the nitrocellulose sheet was performed at 15°C for 16 to 18 hr
at a constant current of 0 .4 amp3. After transfer, the nitrocellulose
sheet was directly used for tmmunoblotting techniques. The
polyacrylamide gel was generally discarded, but in some cases was
stained with Coomassie blue to detect any large molecular weight proteins
which may not have transferred completely.
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Jromunoblotting of P_olyoeptides on Nitrocellulose Membranes
After separation of EIAV polypeptides by SDS-PAGE and subsequent
electrotransfer to nitrocellulose sheets, immunoreactive components
were identified by Immunoblottlng with either a reference antiserum from
a naturally infected horse, or with ascites fluids from monoclonal
preparations described above. These immunoblottlng techniques have
been described previously (Burnette, 1981; Salinovich et a l . , 1986).
Except where otherwise indicated, all incubations were performed 8t room
temperature.
a. Immunoblotting with horse antiserum
The nitrocellulose membrane to which EIAV polypeptides had been
electrotransferred was initially incubated for 30 min at 37°C in 10 mM
Tris-HCl, pH 7.4 with 0.9% sodium chloride (Tris/saline) containing 3%
BSA, in order to block any non-specific binding of reactive antibody to the
nitrocellulose surface. Test antiserum was diluted 1:100 with Tris/saline
containing 3% BSA before incubation with the nitrocellulose membrane for
90 min. The membrane was washed for 10 min in Tris/saline, followed by
two 20 min washes in Tris/saline containing 0.05% NP-40, and finally
washed for 10 min in Tris/saline. The nitrocellulose membrane was then
incubated for 30 min In 50 ml Tris/saline containing 3% BSA and 4.3 x 107
dpm t 1Z5I]-labeled protein A from Staphylococcus aureus. The
nitrocellulose membrane was washed as described above, blotted dry on
absorbent paper, and immunoreactive polypeptides were located by
autoradiography using Kodak X-Qmat XRP film .
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b. Immunoblottlng with ascites fluids
Immunoblottlng with ascites fluids from monoclonal preparations
was performed essentially as above, except that ascites fluids were
diluted only t:SO in Tris/saline with 3% BSA prior to incubation with the
nitrocellulose membrane. After incubation with the ascites fluid, the
membrane was washed and incubated with goat anti-mouse immunoglobulin
6 (IgG) for 90 min (700 mg IgG in 150 ml Tris/saline with 3% BSA). The
membrane was again washed, and subsequent steps Including incubation
with I l a b e l e d protein A and autoradiography were performed as
described above. This extra incubation with goat anti-mouse IgG was
included since protein A binds very weakly, if at a ll, to certain mouse IgG
subclasses (Kronvall, et a l., 1970; MacKenzfe, et a l., 1978; Bruck et a l.,
1982).
Isolation of F3Hl-glucosamine-labeled EIAV glycoproteins
Between 1 x 10® to 1 x 10® dpm of purified EIAV labeled in vivo with
[3H]-g1ucosam1ne was applied per 7.5% polyacrylamide cylindrical gel and
run as described above. After running, the gels were cut into 2mm
fractions, and proteins were eluted from the crushed gel overnight in 50
mM ammonium bicarbonate, pH 8 .0 . Samples of 20 to 50 *il of each
fraction were thoroughly mixed with 2 ml tritosol for scintillation
counting. Fractions corresponding to a single peak of radioactivity were
pooled, and crushed get particles were removed by centrifugation through
Surety column filters in an clinical centrifuge at 1500 rpm for 5 min. The
filtrate was lyophilized to dryness, then suspended in 1.0 ml distilled
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water. Samples of 20 to 40 jil of the final solutions were mixed with 2 ml
tritosol for scintillation counting to determine final activity. Radiolabeled
glycoproteins were stored at -80°C in 500 jil aliquots. In an average
isolation, about 2.0 x 10s dpm of gp90 and 1.2 x 105 dpm of gp45 could be
recovered from 1.0x10® dpm I3H]-glucosamine-labeled intact EIAV.
Recovery of EIAV Glycoproteins or Glvcopeptides bv Lectin Affinity
Chromatography
a. Isolation of unlabeled EIAV glycoproteins
The EIAV glycoproteins gp90 and gp45 were recovered from whole
virus preparations by affinity chromatography on a column of lentil lectin
(from Lens culinaris) covalently bound to Sepharose 48, using procedures
described previously (Montelaro et a l . , 1983). The lentil lectin column
( 0 .8 x 8 cm) typically consisted of a 4 ml total bed volume, and was
equilibrated with 10 to 15 ml 20 mM Tris-HCl, 100 mM NaCl, pH 8 .0 (Buffer
A ), containing 0.1% DOC. Lipid was removed from 5 to 15 mg purified EIAV
by precipitation of viral proteins with 10 volumes of cold acetone and
incubation at 0°C for 30 min. Precipitated proteins were collected by
centrifugation in a Sorvall SS-34 rotor at 10,000 rpm (10,000 x g) for 10
min at 4°C. The protein pellet was suspended in enough Buffer A
containing 0.5% DOC to bring the final protein concentration to 1.0 mg/ml
and frozen overnight. The rapidly thawed virus sample was then diluted
with enough Buffer A containing 0.5% DOC to bring the final protein
concentration to 0 .5 mg.ml, and protein aggregates were completely
disrupted by 2 cycles of Incubation at 37°C for 1.5 min followed by
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sonication for 20 sec. The sample was then applied to the prepared lentil
lectin column at a flow rate of 9 to 10 m l/hr, and protein elution was
monitored by absorbance at 280 nm. The column was washed with 10 to 15
ml Buffer A containing 0.1% DOC, or until a steady baseline was regained.
Glycoproteins binding to the column were eluted with 10 to 15 ml Buffer A
containing 0.1% DOC and 200 mM or-methylglucoside. Fractions containing
unbound (non-glycosylated) and bound (glycosylated) proteins,
respectively, were pooled and dialyzed for 36 hr against 100 mM
ammonium bicarbonate, pH 8 .0 and 12 hr against 50 mM ammonium
bicarbonate, pH 8 .0 . The dialyzed pools were lyophilized to dryness,
suspended in 10 mM sodium phosphate buffer, pH 7 .2 , and stored at
“ 80°C. Protein was quantitated in each pool by the Lowry assay (Lowry et
al. 1951). Generally, 12 mg of whole EIAV treated in this manner yielded
5 to 6 mg protein in the lectin nonbinding pool and 0 .5 to 0 .7 mg protein in
the lectin binding pool.
b. isolation of radiolabeled glycopeptldes
Procedures described previously for isolation of the EIAV
glycoproteins gp90 and gp45 were adapted to accommodate the minute
quantities of material present in radiolabeled samples (Montelaro et a l.,
1983). Columns of lentil lectin (from Lens cullnarls) or concanavalin A
(from Canavalia ensiformis) covalently bound to Sepharose 4B (total bed
volume 1 ml) were poured in 1 ml tuberculin syringes plugged with glass
wool. Proteolytic digests of either [^Hl-labeled or [*^^1]—labeled
glycoproteins were lyophilized to dryness, then suspended in 200 prt
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Buffer A with 0. \ %DOC. Samples were applied to the columns and allowed
to bind for 5 min with flow stopped. After flow was resumed, 0.5 ml or
1.0 ml fractions were collected, and nonbinding components were washed
from the columns with 10 ml Buffer B with 0.1% DOC. Components binding
to the columns were eluted with 10 ml Buffer B containing 0 . \% DOC and 200
mM oc-methyl glucoside. Peaks of radioactivity were located either by
counting fractions directly in a Packard Auto-gamma counter ( ^ 5 | ) , or
30 pi of each fraction were mixed with 2 ml tritosol for scintillation
counting (^H). Fractions corresponding to lectin binding (glycosylated)
peptides were pooled and placed in Spectrapore 3 dialysis tubing, which
had been previously boiled for 15 min in 10 mM EDTA, pH 8.0 to decrease
the pore size such that components of molecular weight greater than 700
would be retained. Samples were dialyzed for 36 hr against 100 mM
ammonium bicarbonate, then 12 hr against 50 mM ammonium bicarbonate.
Dialyzed samples were lyophilized to dryness and stored at -20°C.
Isolation of EIAV Internal Polypeptides bvHPLC Reverse Phase
Chromatography
The internal EIAV protein p9 was purified for subsequent
two-dimensional peptide mapping by reverse phase high performance
liquid chromatography (HPLC) according to modifications of previously
described procedures (Henderson et a l . , 1984; J. Ball» unpublished
results). The solvent delivery system used was a fully programmable
Varian 5000 HPLC with two solvent channels. Samples consisting of 1200 to
1400 pg lentil lectin nonbinding (nonglycosylated) proteins (see above) in
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600 Ml 3.5 M guanidine hydrochloride, pH 3.1 were injected onto a Waters
MBondapak phenyl column (30 cm x 3 .9 mm) equilibrated at 37°C in 0. IX
trifluoroacetic acid (TFA) in water (Solvent A) at a flow rate of 1 ml/min.
After sample Injection, the column was flushed for 1 m1n with Solvent A,
followed by elution of component polypeptides from the column with
increasing amounts of 0.1% TFA in acetonitrile (Solvent B) according to
the following program: (A ll segments consist of linear gradients.)
0 to 25% Solvent B in 25 min;
25 to 41% Solvent B in 32 min;
41 to 45% Solvent B in 20 mini
45 to 55% Solvent B in 20 min;
55 to 60% Solvent B in 5 min.
Elution of polypeptides was monitored by absorbance at 280 nm, and 1 ml
fractions were collected. Fractions corresponding to protein peaks were
pooled and lyophilized to dryness, then suspended in 50 to 90 Ml 10 mM
sodium phosphate buffer, pH 7.2 for subsequent SDS-PAGE analysis.
Protein bands stained with coomassie blue corresponding to the EIAV
polypeptide p9 were excised from the gels for two-dimensional peptide
mapping.
Enzvmatlc Digestion of Radiolabeled Polypeptides
a. Trypsin digestion of [ ' 25J]-labeled polypeptides
Samples containing 40 x 10^ to 70 x 105 dpm were lyophilized to
dryness, suspended in 90 Ml 30 mM ammonium bicarbonate buffer, pH 8 .0 ,
and 10 jil DPCC-treated trypsin (1 mg/ml) was added. The reaction
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mixture was incubated at 37°C for 24 hr. Reaction was stopped by addition
of 6 Mi soybean trypsin inhibitor (1 mg/mi) and incubation at 37°C for 30
min. Digests were lyophilized to dryness and stored at -20°C.
b. Trypsin digestion of radiolabeled polypeptides In polyacrylamide
gel slices
Gel slices containing ['25|]-iabeled polypeptides to be mapped in
two dimensions were placed in separate 10 x 75 mm siliconized test tubes
and dried completely under vacuum snd mild heat. Slices were
rehydrated for 10 min in 30 jjtl DPCC-treated trypsin, followed by the
addition of 500 Ml 50 mM ammonium bicarbonate buffer, pH 8 .0 . Mixtures
were incubated at 37°C for 24 hr, and tryptic peptides were passively
eluted into the reaction buffer. The peptide-containing buffer was
carefully pipetted from the gel slice into an Eppendorf tube, lyophilized to
dryness, and suspended in 30 Ml acetic acid: formic acid: water (15:5:80;
v /v /v ) (electrophoresis solvent) for subsequent two-dimensional peptide
mapping.
c. Neuraminidase digestion of radiolabeled glycopeptides
Procedures described previously (Van Eldik et a l . , 1978; Montelaro
et a l., 1984b) for removal of terminal sialic acid residues from
glycopeptides were modified as detailed below. Samples consisting of 5.5
x 104 to 1.0 x 105 dpm [3 HJ—labeled glycopeptides or 1.5 x 106 to 7.0 x
106 dpm [

l abel ed glycopeptides were diluted to 100 Ml with 50 mM

ammonium acetate, pH 5 .0 , and 5 Ml (25 mUnits) neuraminidase were
added. The reaction mixtures were incubated at 37°C for 6 - 8 hr, followed
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by a second addition of 5 jjl neuraminidase. Reaction mixtures were
incubated an additional 16-18 hr at 37°C, then reaction was stopped by
heating the digests in a boiling water bath for 3 min. Digests were
lyophilized to dryness and stored at -20°C.
Two-Dimensional Peptide and GIvcop^Mide Mapping of EIAV Polypeptides
Two-dimensional peptide and glycopeptide analysis on cellulose-coated
thin layer plates was performed according to previously published
procedures (Elder et a l . , 1977b; Montelaro et a l . , t984a; Salinovich et
a l., 1986; Salinovich and Montelaro, 1986).
a. Two-dimensional peptide mapping
Samples to be analyzed consisted of 1.5 x 10® to 7 .0 x 10® dpm
[ 12 5 l]-labeled tryptic digests of the given EIAV component in 1 to 5 jil
acetic acid: formic acid: water (15:5:80; v /v /v ) (electrophoresis
solvent). The sample was carefully applied in 1/4 jil portions to the
bottom left corner of a cellulose-coated thin layer plate ( 0.1 mm thick on
20 x 20 cm plastic support) at a point 2.5 cm from each edge. Tracking
dye consisting of 2% orange G and 1% acid fuschin in electrophoresis
solvent ( 1/2 mD was applied to the upper right corner of the same thin
layer plate, 2.5 cm from the right edge and 1.25 cm from the top edge.
The entire plate was then dampened with electrophoresis solvent, and
placed in a Pharmacia FBE 3000 flat-bed electrophoresis unit such that the
sample was nearest the anode and the tracking dye was nearest the
cathode. Electrophoresis was performed at 5°C with a constant potential
of 1000 volts, until the tracking dye had migrated 10.5 cm from the right
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edge of the plate. The thin layer plate was air dried, followed by
ascending chromatography in a solvent consisting of 1-butanol: pyridine:
acetic acid: water (6.5:5:i:4; v /v /v /v ) for 8 hr in a direction
perpendicular to the direction of electrophoresis. The plate was again air
dried, and radiolabeled peptides were located by autoradiography using
Kodak X-Omat XRP film . Time of autoradiography varied from 2 hr to 5
days, depending on the polypeptide analyzed,
b. Two-dimensional glycopeptide mapping
Two-dimensional glycopeptide mapping was performed essentially
as described above, with the following modifications. Samples consisted
of lectin-binding glycosylated peptides (see above) isolated after
radfolabeltng and trypsin digestion of the component to be analyzed.
Activity of the samples was considerably lower, containing only 1.5 x 105
to 7 .0 x 10* dpm

labeled glycopeptides or 2 .0 x 10^ to 5.0 x 10^

dpm I^H]—labeled glycopeptides in 5 pi electrophoresis solvent.
Electrophoresis was performed under the same conditions as above, but
the tracking dye was allowed to migrate 15 cm from the right edge of the
plate. Chromatography was performed in a modified solvent consisting of
1-butanol: pyridine: acetic acid: water (5:5:1:7.5; v /v /v /v ) for 10 hr.
(I25|]_iabeled glycopeptides were located by autoradiography as above,
but thin layer plates containing t 3 H3—labeled glycopeptides had to be
dipped in 0.5% PPO in 2-methylnaphthalene in order to perform
autofluorography. Time of autofluorography was generally two to three
weeks.
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Computer A nalysis of EIAY-Amino Acid Sequences
A ll computer analyses were performed using programs offered by
Intelligenetics, Inc. through its Bionet system, with an IBM-PC serving as
a local terminal. Hydropathic analysis of the predicted EIAV envelope
amino acid sequence derived from the previously reported prototype DNA
proviral sequence (Rushlow et a l . , 1986) was performed according to the
algorithms developed by Kyte and Doolittle (1982). Prediction of
secondary structure from amino acid sequences was performed according
to the algorithms and criteria developed by Chou and Fasman (1974,
1978). All parameters assigned to amino acids for these calculations are
given in Appendix III.

CHAPTER 3
RESULTS

I. COMPARATIVE ANALYSIS OF FOUR CONSECUTIVE EIAV ISOLATES
The antigenic properties of four EIAV isolates were compared in
neutralization assays, as well as In Immunoblot analyses using either
polyclonal or monoclonal antisera. Structural studies of these same
isolates included analysis of the component polypeptides by SDS-PAGE and
two-dimensional mapping of radioiodinated tryptic peptides. Previous
preliminary studies involving structural analysis of EIAV isolates
(Montelaro et a l . , 1984a) included only the major surface glycoprotein
gp90, and the internal non-glycosylated polypeptides p26, p i5, and p9.
In the present study, the second surface antigen gp45 was also subjected
to two-dimensional peptide analysis. In addition, the two-dimensional
mapping procedure was modified such that glycosylated peptides of both
gp90 and gp45 could be analyzed for the first time.
EIAV Isolates
EIAV Isolates for this study were recovered from experimentally
infected Shetland ponies in which the cell-adapted prototype strain of the
virus had been serially passaged (Orrego et a l . , 1982). Figure 5 shows
the inoculation scheme used, as well as virus isolate designation and
replication path. The four Isolates used in this study (P 3 .1-1 through
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Figure 6 . Plot of daily rectal temperature of a third passage animal,
showing disease episodes and points at which virus isolates were
recovered.
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P 3 .1-4) were recovered during the first four sequential disease episodes
in one of two third passage animals. Figure 6 shows a plot of daily rectal
temperature of this animal, as well as the points at which the virus
isolates were recovered. No virus could be recovered from plasma taken
between episodes, which is in agreement with previous findings COrrego et
a l., 1982). For subsequent biochemical studies, the predominant virus
present in the plasma during each episode was isolated by endpoint
dilution, then propagated in fetal equine kidney cells and purified as
described in Materials and Methods.
Antigenic Studies
a) Serum neutralization
Neutralization assays were Initially performed by the virus
dilution-constant serum method, using serum from the same animal
(Salinovich et a l . , 1986). The results of these assays are shown in Table
III.

In general, serum recovered between disease episodes was capable

of neutralizing any previous EIAV Isolates, but could not neutralize any
subsequent isolates. Serum taken 31 days postinoculation showed
equivalent reactivity toward both isolates P 3 .1-1 and P 3 .1-3, which may
be an artifact of the low neutalizing ability of this serum. The failure of
serum taken 158 days posttnoculation to neutralize isolate P 3 .1-4 may be
due to a combination of factors. The animal may not have had sufficient
time to produce neutralizing antibody only 21 days after the last disease
episode. Also, it has been previously demonstrated that EIAV infects
monocytes and macrophages, and may alter the infected animal's ability
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Table I I I . Serum neutralization indeces of sera collected at different
times after inoculation.

Neutralization indexb of serum collected
on the following day postinoculation:
Virus strain

VIDa

31

125

158

P3.1-1

13

1.5

3.0

3.0

P 3 .1-2

41

0.5

3.0

3.0

P 3 .1-3

99

1.5

2.0

1.0

P3.1-4

137

1.0

1.0

1.0

8 Days postinoculation when plasma was collected.

b Log jo serum neutralization index (positive if 2.1 .5 ) as described in
Materials and Methods.

,
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to mount an effective immune response (McGuire et a l . , 1971; Ushimi et
a l., 1972).
The results of these neutralization assays indicate that distinct
antigenic variants of EIAV are associated with each disease episode 1nthe
sequential series, which confirms and extends previous reports of
antigenic variation in EIAV (Kono et a l . , 1973; Montelaro et a l . , 1984a;
Salinovich et a l., 1986). In addition, the data demonstrate that the time
required for EIAV to vary Its antigenic reactivity such that It can escape
host immune defenses can be as short as 28 days (the time between the
recovery of isolates P 3 .1-1 and P 3 .1 -2 ). Thus, the time frame required
for antigenic variation in EIAV is considerably shorter than that reported
for visna virus, which requires 1 to 2 years for the appearance of
antigenically distinct virus strains in the persistently infected animal
(Scott e t a l . , 1979; Clements et 8 l . , 1980).
b) immunoblot analysis
As shown In the neutralization studies, these four Isolates are
recognized by the host to be antigenically distinct, thus providing a unique
system with which to study antigenic variation in a lentivirus. Initially,
immunoblot analysis of the EIAV isolates with a polyclonal equine
reference antiserum was performed to Identify EIAV polypeptides
recognized by the host’s immune response during natural infection. Whole
virus preparations of each of the four isolates, as well as the prototype
strain, were disrupted and the component polypeptides were separated by
SDS-PAGE in 10% gels. A typical gel pattern obtained after coomassle
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staining is shown in Figure 7A. Since gp90 and gp45 together comprise
only 10% of the viral protein (Parekh e t a l., 1980), they cannot be
easilylocated in this protein pattern. The internal proteins p26, p15,
pi 1, and p9, which comprise almost 85% of EIAV by weight, can all be
easily identified in the isolates analyzed.
Once the polypeptide components of each isolate were separated by
SDS-PAGE, they were transferred to a nitrocellulose membrane and
Immunoblotted with a broadly-reactlve reference antiserum obtained from
a naturally infected horse (designated Lady). The resulting immunoblot
of the five Isolates is shown in Figure 7B. This broadly-reactive
antiserum predominantly recognized both gp90 and gp45 from the
prototype strain of the virus (lane 1 ) , even though they are present in
relatively low quantities (about 4 ug and 2 Mg* respectively). In
contrast, this antiserum only weakly recognized p26, even though it is
present in much higher quantities than the two glycoproteins (about 27
jig ). This antiserum recognized both glycoprotein components, as well as
the p26 component, from all of the EIAV isolates analyzed. Some
variation, however, was observed in the degree of reactivity of the
reference antiserum to the glycoproteins of the different isolates. The
serum displayed a very poor reactivity to the gp45 component of isolate
P 3.1-3, whereas it reacted strongly with gp45 from the remaining isolates
(Salinovich et a l., 1986). Also, variation in electrophoretic mobility of
both the gp90 and gp45 components from all five isolates was evident,

Fig ure 7 . Analysis of polypeptides from EIAV isolates, (A ) SDS-PAGE
separation of virion polypeptides, visualized by coomassle staining. ( 8 )
Immunoblot analysis of a similar SDS-PAGE separation with a broadly
reactive polyclonal antiserum. Equal amounts (50jig) of each virus
isolate are present in each lane. Prototype EIAV was included as a
reference.

58

suggesting that some structural changes may have occurred in these two
glycoproteins.
To further identify contributions of gp90 and gp45 to the antigenic
variation demonstrated in the neutralization studies, immunoblot analyses
similar to that described above were performed with the four third
passage isolates using a panel of monoclonal antibodies raised against
either gp90 or gp45 recovered from the prototype strain of EIAV. As
shown in Table IV, all five monoclonal antibodies specific for gp90 reacted
strongly with this glycoprotein from the prototype virus. A similar
pattern of reactivity was seen for gp90 from isolate P 3 .1-1.
Interestingly, isolates P 3 .1-1 and P 3 .1-3, which exhibited equivalent
neutralization properties, differed In the reactivity of only one
monoclonal antibody, suggesting that they indeed express very similar
antigenic properties. All four isolates could be distinguished
antigenically on the basis of their reactivity with this panel of
gp90-specific monoclonal antibodies, which parallels and confirms the
findings of the neutralization assays. This data shows for the first time
the occurrance of antigenic variation at distinct epitopes of gp90 from
EIAV isolates recovered only weeks apart from a single animal.
In contrast, the three monoclonal antibodies specific for gp45
recognized this glycoprotein from all four EIAV isolates as well as the
prototype strain. Since no competitive binding assays have been
performed with these monoclonals, the possibility that all three recognize
the same epitope cannot be excluded. Therefore, ft appears from the
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Table IV . Reactivity patterns of eight monoclonal antibodies specific for
either gp90 or gp45. Monoclonal antibodies were generated against the
glycoproteins of prototype EIAV, and were then used to screen five EIAV
antigenic variants in immunoblot analyses. A (+) denotes positive
reactivity, a ( - ) denotes no reactivity, and a ( + /- ) denotes very weak
positive reactivity.

reactivity

prototype

P3.1-1

P 3 .1-2

P 3 .1-3

1

gp90

+

+

+ /“

+

—

2

gpQO

+

+

+ /-

+

—

86

gp90

+

+

+

+

+

95

gp90

+

+

+

+

+ /-

115

gp90

+

+

+

—

+

30

gp45

+

+

+

+

+

101a

gp45

+

+

+

+

+

105

gp45

+

+

+

+

+

MAb

aSubtyped as lgG2b*
IgGl-

P3.1-4

remaining monoclonal antibodies are subtyped as

60

results obtained with this limited panel of monoclonal antibodies that while
both gp90 and gp45 may be involved in antigenic variation in EIAV, gp90
contributes more to this variation than does gp45.
Structural Analysis

'

a) SDS-PAGE
The variation in electrophoretic mobility observed for the gp90 and
gp45 components of the four EIAV isolates in the immunoblottlng analyses
suggests that structural variation may be occurring in these
glycoproteins. Structural variation has been previously demonstrated by
two-dimensional peptide analysis of the gp90 component from EIAV
Isolates recovered months apart from different experimentally infected
animals (Montelaro et a l., 1984a). To determine if such structural
variation could be detected in the glycoprotein components of EIAV
isolates recovered only weeks apart from a single animal, similar
analyses were conducted with each of the four isolates presently under
study. In preliminary experiments, each isolate was purified after
propagation in tissue culture, followed by separation of the viral
polypeptides by lentil lectin affinity chromatography. The components of
the lectin binding (glycosylated) and non-binding (non-glycosylated)
protein pools were then separated by SDS-PAGE in 10% gels and visualized
by coomassie staining.
As seen in Figure 8A, the lectin non-binding pool of each isolate
contained the internal viral polypeptides p26, p i5, pi 1, and p9. A ll four

Figure 8 .

SDS-PAGE analysis of lentil lectin non-binding (A ) and binding

(B) polypeptide pools of four EIAV isolates. Prototype EIAV was included
as a reference.
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internal polypeptides exhibited essentially identical electrophoretic
mobilities, regardless of the isolate from which they were derived. The
lectin binding pools from each isolate, shown in panel B, contained the
viral glycoproteins gp90 and gp45, as well as several contaminating
cellular and/or serum glycoproteins. As in the immunoblot analyses, the
electrophoretic mobility of both the gpQO and gp45 components varied
between isolates, whereas the mobilities of the internal viral polypeptides
remained constant. In addition, the mobilities of the bands tentatively
identified as contaminating glycoproteins also remained constant. This
observed variation in mobility for both EIAV glycoproteins was highly
reproducible in different viru 3 preparations, and did not change even
after prolonged passage in tissue culture. These results closely parallel
the previous studies with other EIAV variants (Montelaro et a l . , 1984a),
where the gp90 and gp45 components also exhibited variations in their
electrophoretic mobilities.
b) Two dimensional peptide analysts — gp90 and gp45
Since it has not yet been possible to purify significant quantities of
gp90, structural analysis of this glycoprotein was performed by two
dimensional peptide mapping using procedures originally developed by
Elder et al. (1977b), and modified as described previously (Montelaro et
a l . , 1984a; Salinovich et a l . , 1986). These procedures include the
radioiodination and trypsin digestion of polypeptides within a
polyacrylamide gel matrix, such that single proteins which cannot be
otherwise purified can be excised from polyacrylamide gels after
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electrophoretic separation and analyzed effectively. As is apparent in
Figure 8 B, it is virtually impossible to separate the gp90 component of
several of the isolates (P 3 .1-1, P 3 .1-2, and P 3.1-3) from a
closelymigrating cellular contaminant with the continuous sodium
phosphate gel system used. To obtain the necessary separation, the
components of the lectin binding pool from each isolate were separated
using the discontinuous gel system developed by Laemmli (1970). The
resultant analysis of these five EIAV Isolates in a 10* gel Is shown In
Figure 9. Sufficient separation was achieved between gp90 and the higher
molecular weight contaminant, even in isolates where the migration of
gp90 is slower than that in prototype virus.
Once sufficient separation was achieved, protein bands corresponding
to the gp90 component of each isolate were excised from the gel,
radioiodinated and trypsin digested as described (Montelaro et a l . , 1984a;
Salinovich et a l., 1986), and the subsequent radiolabeled digests were
subjected to two dimensional peptide analysis. To facilitate direct
comparison of maps from the different isolates, the gp90 component from
the four third-passage isolates were mapped at the same time under
identical conditions. The gp90 component from prototype EIAV was
Included in each analysis as a control. To obtain a systematic
comparison, each isolate is compared to its immediate predecessor, such
that P 3 .1-2 is compared to P 3 .1-1, P 3 .1-3 is compared to P 3 .1-2, and
P 3 .1-4 is compared to P 3 .1-3.

Figure 9 .

SDS-PAGE analysis of the lentil lectin binding polypeptide

pools of four EIAV isolates, using a discontinuous electrophoresis
system. Prototype EIAV was included as a reference.
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As seen in Figure 10, there are both peptide additions and deletions
occurring in the gp90 peptide patterns in each pair of isolates examined.
In addition, no two isolates exhibited identical gp90 peptide patterns.
Three to five maps of each virus isolate were studied, and the denoted
peptide differences were consistently observed in all maps. Also, the
maps obtained were completely reproducible, even after passage of the
virus strains in tissue culture for up to six months. These results
demonstrate that structural variation can be seen in gp90 from EIAV
isolates recovered only weeks apart from the same animal, and that these
structural changes occur concurrently with antigenic changes in this
surface glycoprotein.
Since the gp45 component also exhibited electrophoretic mobility
changes between virus isolates, this glycoprotein was included in the
two-dimensional peptide analysis. However, previous attempts to obtain
peptide patterns of gp45 from EIAV variants using the above procedures
failed due to high background, possibly due to contamination from cellular
glycoproteins migrating with gp45 in sodium phosphate gels. Such
contamination can clearly be seen in Figure 9, where three bands are
present in the 41,000 to 45,000 da region of this 10% Laemmli gel, instead
of the one broad band seen in the corresponding regfon of the 10%sodium
phosphate gel shown in Figure 8 B. To identify which of the three bands
evident in the Laemmli gel is actually gp45, separate samples of
^H-glucosamine-labeled gp45 and lentil lectin binding components from
prototype EIAV were separated by electrophoresis in adjacent wells of a
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Fig ure 10- Two-dimensional tryptic peptide maps of the gp90 component
from four EIAV isolates. Arrows and open circles indicate peptide
additions and deletions, respectively, observed when each isolate is
compared to its immediate predecessor. Electrophoresis was performed
in the horizontal direction (le ft to right), followed by ascending
chromatography in the vertical direction.
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102 Laemmli gel. After electrophoretic separation, protein bands were
visualized by appropriate methods, and the two profiles were compared
such that the band corresponding to gp45 could be located.
As seen in Figure 11 (lane 3 ), 3 H-labe1ed gp45 migrates in the gel in a
rather wide band, which coincides with the lower two bands Cb‘ and "c")
of the triplet seen in this region of the coomassie stained gel (lane 2 ).
Location of gp45 by immunoblot analysis yielded identical results.
Therefore, although the uppermost band of the three C a’ , lane 2) could
be tentatively eliminated, both lower bands were possibly gp45. Thus,
the two lower bands were excised from the gel separately, and each was
subjected to two-dimensional peptide mapping.
The resultant peptide patterns for these two protein bands, shown In
Figure 12, are surprisingly similar, suggesting that the two bands
represent different forms of gp45. In contrast, the peptide pattern
obtained for band "a" was completely distinct from those of bands "b* and
"c“ (data not shown). There are only six peptides present In the map of
the upper band which are not present in the map of the lower band
(designated by open circles), and two peptides present in the lower band
which are not in the upper band (designated by arrow s). Since it appears
that both bands are present In 3 H-glucosamine labeled gp45, It Is highly
unlikely that one band represents a non-glycosylated form of this
glycoprotein. Also, the peptide map of the larger band possesses several
additional peptides not present in the map of the lower band, suggesting
that the lower band may be derived from the upper band by proteolytic

30K -

Fig ure 11.

Location of gp45 In a 10% discontinuous SDS-PAGE analysis.

Lane 1 - - standard molecular weight markers; Lane 2 — coomassie
stained gel analysis of the lentil lectin binding polypeptide pool from
prototype EIAV; Lane 3 — I^H]-glucosamine labeled gp45 from prototype
EIAV.
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9P 45$!

F ig ure 12.

Two-dimensional tryptic peptide maps of the two possible

gp45 components. Arrows and open circles represent peptide additions
and deletions, respectively, observed when the lower band map is
compared with the upper band map.
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cleavage. Such proteolytic cleavage of the transmembrane env gene
product has been documented in Rauscher murine leukemia virus, in which
p!5E is cleaved to form plZE (Karshin, et a l., 1977; Jamjoon, e t a l .,
1977).
Once the protein bands corresponding to the gp45 component had been
identified, two-dimensional peptide patterns for this glycoprotein from
each of the four third passage isolates were generated, and are shown in
Figure 13. Both gp45 bands for each Isolate were mapped together, such
that the maximum amount of variation in this component could be
detected. The large amount of background radioactivity which had been
seen in previous attempts to map gp45 was effectively eliminated,
allowing this glycoprotein to be analyzed for the first time. As was seen
for the gp90 component, there are both peptide additions and deletions
occurring in gp45 between each isolate and its immediate predecessor.
Also, no two isolates exhibited identical gp45 peptide patterns. As with
the gp90 maps, three to five maps of gp45 from each Isolate were
analyzed, and the peptide patterns obtained were highly reproducible,
even after prolonged passage of these isolates in tissue culture. These
results demonstrate for the first time that structural variation occurs in
both surface glycoproteins of EIAV during replication 1n a single animal.
d) Glycopeptide analysis — gp90 and gp45
The two dimensionat mapping technique used above to analyze gp90
and gp45 does not resolve peptides containing carbohydrate (Montelaro et
a l . , 1984a). Glycosylated peptides migrate In the first dimension
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P3.1-1

P3.1-2

P3.1-3

P3.1-4

•*

Figure 13. Two-dimensional tryptic peptide maps of the gp45 component
from four EIAV isolates. Arrows and open circles indicate peptide
additions and deletions, respectively, observed when each isolate is
compared to its immediate predecessor.
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electrophoresis, but do not migrate in the second dimension
chromatography, thus forming a characteristic pattern of unresolved
peptides extending from the sample origin across the bottom of the peptide
pattern. It has previously been shown that at least 10% to 15% of the
natural host immune response to gp90 is directed toward the carbohydrate
moiety of the molecule (Montelaro et a l . , 1984b), Also changes in the
glycosylation pattern of other viral surface glycoproteins can drastically
alter their antigenicity (Alexander and Elder, 1984; Kawoaka et a l.,
1984). Therefore, it is important to be able to analyze glycosylation
patterns in the EIAV gp90 and gp45 components.
Conventional methods for the characterization of carbohydrates, which
require relatively large amounts of purified material, cannot be
performed with either EIAV glycoprotein, since neither has yet been
purified in sufficient quantities. In addition, analysis of glycoprotein
oligosaccharides employing gel filtration procedures, although useful for
some comparisons, are of relatively low resolution and provide no
information about sites of glycosylation (Hunt and Wright, 1981, 1983).
Therefore, we sought to modify the two-dimensional peptide mapping
procedure such that glycosylated peptides could be resolved, and
glycopeptide structural analysis could be performed with gp90 and gp45
from the panel of EIAV isolates.
The two well characterized glycoproteins, fetuin andaj-acid
glycoprotein, were used for the development of the modified mapping
technique. Each is readily available commercially in large quantities,
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and with rather high purity. The apacid glycoprotein was chosen since it
is a relatively small glycoprotein (MW = 21,000) which contains five
N-linked carbohydrate side chains whose structure and position of
attachment in the amino acid sequence are known (Figure 14A) (Schmid et
a l., 1973; Schwarz man et a l . , 1978). Fetuln was Included because 1t
contains three O-linked as well as three N-linked carbohydrate side
chains, the structures of which have been previously determined (Figure
MB) (Spiro and Bhoyroo, 1974; Nilsson et a l . , 1979).
The two glycoproteins were radiolodinated by the chloramlne-T'
method, followed by 24 hr trypsin digestion. The resultant digests of both
standard glycoproteins were analyzed by conventional two-dimensional
peptide mapping, the results of which are shown in Figure 15A. The
characterisitic unresolved pattern is clearly evident at the bottom of the
maps for both glycoproteins. Glycosylated peptides were then separated
from the digests by affinity chromatography on columns of either
conconavalin A (fo r fetuin) or lentil lectin (fo r ap acid glycoprotein)
bound to Sepharose 4B, and analyzed by the same peptide mapping
technique (Figure 15B). As demonstrated previously for EIAV gp90
(Montelaro et a l . , 1984a), the glycosylated peptides of these two
standard glycoproteins failed to migrate in the second dimension
chromatography.
The first approach taken in the development of an effective
glycopeptide solvent was to decrease the amount of 1-butanof and
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fetuin

oc,-acicJ

•A #
• I t

B

feluin

a.-acid

Figure 15. Two-dimensional tryptic peptide maps of the standard
glycoproteins. (A ) Peptide patterns obtained for digests of fetuin and
a p acid glycoprotein. (B) Peptide patterns obtained for the lectin binding
(glycosylated) peptide pools of digests of fetuin and ap acid glycoprotein.
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increase the amount of water in the peptide chromatography solvent, such
that migration of the more hydrophilic glycopetides would be favored. It
was found that changing the ratios of the components from 6.5:5M:4 to
5:5M:7.5 ( 1-butanol: pyridine: acetic add: water; v /v /v /v ) produced a
solvent in which the glycosylated peptides of both fetuin and apacid
glycoprotein migrated during chromatography.
Once this suitable solvent was developed, full two dimensional
patterns of the glycosylated peptides of the two standard proteins were
produced. Since gp90 is at least twice the molecular weight of the
standard protein fetuin, this glycoprotein from the EIAV isolate P 3 .1-1
was also included to determine if size might be a prohibitive factor in this
analysis. Electrophoresis in the first dimension was essentially identical
to that in peptide mapping, except that migration of the tracking dye was
increased from 10.5 cm to 15 cm to obtain better resolution. Ascending
chromatography was performed in the modified solvent for 10 hr,
followed by visualization of radioactive glycopeptides by autoradiography.
The resultant two-dimensional glycopeptide maps for all three
glycoproteins are shown in Figure 16. The glycopeptide pattern obtained
for a p acid glycoprotein, which contains only N-linked carbohydrates, is
relatively simple, consisting of four sets of vertically arranged doublets.
The corresponding pattern obtained for fetuin, which contains both N- and
O-linked carbohydrates, is quite distinct from that of a p ac id
glycoprotein, even though the N-linked carbohydrates from both

fetuin

a,-acid

*«

•V

i
9P«>

•7

Figure 16. Two-dimensional tryptic glycopeptide maps of the lectin
binding pools of digests of fetuin, a p acid glycoprotein, and the gp90
component of EIAV isolate P 3 .1-1.
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glycoproteins are essentially identical (Figure 14). This observation
demonstrates that the peptide to which the carbohydrate is attached
contributes to the final glycopeptide pattern obtained. The glycopeptide
pattern obtained for EIAV gp901s the most complex of the three patterns,
but the resolution of components in the map was still maintained. In
addition, an identical pattern was obtained for [3 H]-glucosamine-1abeled
gp90 from this isolate under identical conditions (data not shown),
indicating that radlolodination of amino acids is as effective In detecting
gp90 glycopeptides in this procedure as in vivo labeling of
oligosaccharides.
Interestingly, both gp90 and apacid glycoprotein exhibited vertical
patterns of glycopeptides which electrophorese together, but differ
slightly in their migration in the chromatography solvent. It is possible
that these glycopeptide patterns are due to microheterogeneity in the
carbohydrate moiety, a property which has been documented in several
glycoproteins (Schmid et a l . , 1977; Schwartzmann et a l . , 1978). Since a
logical contributor to this microheterogeneity is sialic acid, which Is
usually found at the non-reducing end of a carbohydrate chain, the effect
of neuraminidase digestion of the glycopeptides of these two proteins on
the resultant patterns was determined.
The results of such an experiment are shown in Figure 17. The
glycopeptide groups seen in the patterns obtained before neuraminidase
digestion (panel A) were numbered such that 3 direct comparison of the
patterns could be made. Two of the four groups seen in the untreated

Figure 17. Effects of neuraminidase treatment on glycopeptide
patterns. (A ) Two-dimensional tryptic glycopeptide maps of ap acid
glycoprotein and EIAV gp90 from P 3 .1-1. (B) Two-dimensional
glycopeptide maps of these two glycoproteins after neuraminidase
treatment. Glycopeptide groups were assigned arbitrary numbers for
identification.
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patterns for both glycoproteins were eliminated upon neuraminidase
digestion (panel B), but the number of individual glycopeptides in the
remaining groups were totally unaffected. Also, no additional groups
appeared 1n these maps for either glycoprotein. It therefore appears that
groups 2 and 4 in both glycopeptide maps represent naturally occurring
asialo forms of groups 1 and 3, respectively. Thus, sialic acid
contributes mainly to the electrophoretic behavior of a given glycopeptide
in this procedure, and not to the generation of vertical patterns. It is
highly unlikely that these vertical patterns are due to incomplete trypsin
digestion, since no such vertical patterns are apparent in the peptide
maps of either glycoprotein. Therefore, these vertical groups are most
likely due to heterogeneity 1n carbohydrate residues other than sialic
acid.
With a procedure now available for the analysis of glycosylated
peptides, the gp90 and gp45 components from the four EIAV isolates
previously analyzed by two-dimensional peptide mapping were then
subjected to two-dimensional glycopeptide mapping as just described
(Figures 18 and 19). A ll comparisons between isolates were performed
as in the peptide mapping studies, except that vertical glycopeptide
groups were compared Instead of individual glycopeptides due to possible
microheterogeneity. In contrast to the peptide maps obtained for these
components, in which no two isolates exhibited identical maps, repetition
of a given glycopeptide pattern is seen In both gp90 and gp45. Two distinct
patterns were seen for the gp90 component from these Isolates, one
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Figure 18. Two-dimensional glycopeptide maps of the gp90 component
from four EIAV isolates. Arrows and open circles indicate glycopeptide
additions and deletions, respectively, observed between isolate P3.1-3
and the remaining isolates.
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P3.1-1
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Figure 19. Two-dimensional glycopeptide maps of the gp45 component
from four EIAV isolates. Arrows and open circles indicate glycopeptide
additions and deletions, respectively, observed when each isolate is
compared to Its immediate predecessor.
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expressed by P 3.1-1, P 3 .1-2, and P 3 .1-4, and a very distinct pattern
expressed by P 3 .1-3 (Figure 18). Two patterns were also seen for the
gp45 component, which were expressed in an alternating fashion — one
pattern exhibited by P 3 .1-1 and again by P 3.1-3, and the other by P 3 .1-2
and P 3.1-4 (Figure 19). Thus it appears that the glycosylation patterns of
either glycoprotein may vary between isolates, and that expression of
differing patterns in the two glycoproteins is independent of one another.
The results of the peptide and glycopeptide mapping studies of the
four EIAV isolates indicate that structural variation can occur in both
surface glycoproteins gp90 and gp45, and that this variation is not limited
to changes in the peptide backbone, but can also occur in the glycosylation
pattern of both components as well.
d) Two-dimensional peptide mapping — p26, p15, and p9
The internal EIAV proteins p26, p i5, and p9 from the four
third-passage isolates were also analyzed by two-dimensional peptide
mapping. The pi 1 component was not Included in these analyses, since it
contains no tyrosyl residues and, therefore, cannot be effectively
radioiodinated (Montelaro et a l . , 1982). The two-dimensional patterns
for the p26 component from these four isolates, shown in Figure 20, are
not only identical to each other, but are also Identical to the pattern
obtained for p26 from prototype EIAV. These results contradict the
findings of previous structural analysis of p26 from EIAV variants
recovered months apart from different animals, in which this internal
polypeptide exhibited structural variation coincident with the return of
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Figure 20. Two-dimensional tryptic peptide maps of the p26 component
from four EIAV isolates.
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EIAV virulence (Montelaro et a l . , 1984a). The only observed difference
between the two analyses is the type of polyacrylamide gel system used to
separate the viral polypeptides for subsequent analysis. In the previous
studies, the p26 component was excised from 10% sodium phosphate gels
(Parekh e t a l . , 1980; Montelaro et a l., 1982), while in the present study,
15% discontinuous gels were used (Laemmli, 1970). As seen in Figure 21,
there is a faint protein band in several of the isolates which migrates just
beneath the p26 component. Since this lower molecular weight band 1s not
evident in the 10% sodium phosphate gel of these same samples (Figure
8 A ) , it is possible that the previous maps obtained for p26 included the

peptides of this contaminant as well. This hypothesis is supported by the
fact that structural changes previously noted all corresponded to peptide
additions (Montelaro et a l . . 1984a). Therefore, it appears that no
structural variation occurs in the p26 component from EIAV variants
recovered either months apart from different animals or weeks apart
from the same animal.
Similar results were obtained for both the p15 (Figure 22) and the p9
components (Figure 23). The p9 components were partially purified from
lectin non-binding polypeptide pools by reversed phase HPLC prior to
separation by SDS-PAGE and peptide mapping to remove contamination by a
9000 da fragment of p i5 (J . Ball, unpublished results). The peptide
patterns obtained for each component from the four EIAV isolates were
identical to each other, suggesting that structural variation does not
occur in any of the three internal EIAV polypeptides analyzed. Thus it

Figure Z1 . SDS-PA6 E analysis of the lentil lectin non-binding
polypeptide pools from four EIAV isolates in a discontinuous system.
Prototype EIAV was included as a reference.
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P 3.1-3

Figure 22 . Two-dimensional tryptic peptide maps of the p i 5 component
from four EIAV Isolates.
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P 3.1-4

Figure 23 . Two-dimensional tryptic peptide maps of the p9 component
from four EIAV isolates.
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appears that structural variation observed in EIAV during persistent
infection is specific for the virion glycoproteins, which are subject to
immune selection mechanisms.
II. EXTENT OF ANTIGENIC AND STRUCTURAL VARIATION AMONG EIAV ISOLATES
It was previously shown that EIAV isolates recovered months apart
from different experimentally infected animals exhibited varied
antigenicity as well as structural variation in the peptide portion of the
surface antigen gp90 (Montelaro et a l . , 1984a). It has now been
demonstrated that EIAV variants recovered only weeks apart from the
same animal also exhibit antigenic variation. In addition, structural
variation was detected in both surface antigens gp90 and gp45, and this
variation was seen both In peptide structure and glycosylatlon pattern
(Salinovich et a l . , 1986). A major unanswered question is the extent of
variation possible in EIAV. Are there only a small number of antigenic
strains, as with the three poliovirus serotypes (Diamond et a l . , 1985), or
do numerous variants exist, as with the over 120 rhinovirus serotypes
(Cooper et a l., 1978)? To address this question, structural analysis of
nine EIAV isolates in addition to prototype virus was performed by peptide
and glycopeptide mapping of their component polypeptides. In addition,
antigenic relationships were examined by screening these ten strains with
a limited panel of glycoprotein-specific monoclonal antibodies.
EIAV Isolates
The panel of isolates for this study included the prototype strain
and the four strains used in the previous antigenic and structural
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analyses. In addition, five EIAV strains recovered from a second
experimentally infected third passage animal were included. This animal
received the same plasma inoculum as the previous animal, and therefore
represents a parallel infection. The rectal temperature profiles for both
animals are shown in Figure 24, and virus isolates were recovered as
indicated. The first four isolates P 3.1-1 through P 3 .1-4 were recovered
from an animal exhibiting classical chronic EIA, which is characterized by
recurring episodes of disease. The Isolates P 3.2-I through P3.2-3 also
represent chronic EIAV, but the disease episodes during which these
isolates were recovered were separated by only 17 and 26 days,
respectively. There was a period of 5 months separating isolates P3.2-3
and P3.2-4, representing the Inapparent stage of the disease where the
animal is asymptomatic for extended periods but remains a carrier of the
virus. This set of nine EIAV strains therefore represents a broad range of
clinical events characteristic to EIA.
Antloenic Studies
Unfortunately, antigenic studies for the five isolates P 3.2 -I through
P3.2-5 was limited. Neutralization assays with autologous antisera could
not be performed, since sufficient serum samples were not taken from
this animal during the course of disease (A . Orrego, Ph.D. thesis,
Louisiana State University, Baton Rouge, 1983). In addition, only a very
limited panel of monoclonal antibodies generated against gp90 from
prototype virus was available. Despite these limitations, some antigenic
comparisons could be performed.
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Initially, the polypeptide components of these ten EIAV strains were
separated by SDS-PAGE of equal quantities (50 >iq ) of each isolate,
followed by immunoblot analysis with the braodly reactive reference
antiserum from a naturally infected horse (designated Lady). A typical
immunoblot pattern thus obtained is shown in Figure 25. The now
characteristic variation in electrophoretic mobility of both the gp90 and
gp45 components from all the EIAV strains was clearly evident, while the
mobility of the p26 component remained constant. This broadly reactive
antiserum recognized the gp90, gp45, and p26 components from all
isolates tested, but there was some variation in the relative reactivity of
this serum with the gp45. component from several of the isolates. This
antiserum exhibited Its strongest reactivity toward gp45 from isolate
P 3 .2 -1 . This antiserum also exhibited equivalent reacitivity for gp45
from prototype, P 3.1-1, P 3.1-2, and P3.2-2 through P3.2-5, but
exhibited lower reactivity toward this component from both P 3 .1-3 and
P3.1-4.
Similar immunoblot experiments were performed with these isolates
using four available gp90-specific monoclonal antibodies available, the
results of which are given in Table V. With these monoclonal antibodies,
isolates P 3 .1-1 through P 3 .1-4 and P3.2-2 could all be distinguished
antigenically. Isolate P3.2-5 may also by antigenically distinct, or may
have the same pattern of reactivity as isolate P 3 .1-3. Because of the
limited number of epitopes represented by this panel of antibodies, it was
not possible to distinguish isolates P3.2-1, P3.2-3, andP3.2-4
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Immunoblot analysis of component polypeptides of 10 EIAV

strains with a broadly reactive polyclonal antiserum.

T a b le V . R e a c tiv ity p a tte r n s o f fo u r m o n o clo n al an tib o d ie s s p e c ific
f o r g p 90. Monoclonal antibodies were generated against the glycoproteins of
prototype EIAV, and w ere then used to screen ten EIAV varian ts in immunoblot
analyses. A (+ ) denotes a positive re a c tiv ity , a ( - ) denotes no rea c tiv ity , and
a ( + / - ) denotes a v e ry weak positive rea c tiv ity .
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* Hybridoma cells producing MAb #2 w ere lost before ascites fluid could be
produced fo r the analysis of isolates P 3.2-1 through P 3 .2 -5 .
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antigenically. Thus this panel of isolates includes at least 6 antigenic
EIAV variants. It is interesting to note that MAb #86 recognized gpSO from
all EIAV isolates tested, and therefore may represent an epitope of gp90
which is conserved.

<•

Structural Analysis — PS.2-1 through P5.2-5
Before total structural variation among the ten EIAV isolates was
determined, the five isolates P3.Z-1 through P3.2-5 were compared to
each other. Structural analysis of the component polypeptides of these
five isolates was performed by two-dimensional peptide and glycopeptide
mapping, as described above for the previous EIAV strains. Comparisons
were performed as before, with each isolate being compared to its
Immediate predecessor, such that P3.2-2 was compared to P 3.2-1, and so
forth. Three to five maps of each isolate were generated, and maps were
completely reproducible.
The peptide (Figure 26) and glycopeptide (Figure 27) patterns thus
obtained for the gp90 component from the five isolates revealed some
very interesting results. Again, peptide additions and deletions occurred
in the peptide patterns from these isolates, with a notable exception. The
peptide patterns for gp90 from isolates P3.2-2 and P3.2-3 were identical
to one another; this Is the first time that any two Identical gp90 peptide
patterns have been demonstrated. This result may not necessarily
indicate that the peptide structure for the two molecules is the same,
since possible structural changes could have occurred in peptides lacking
tyrosyl or histidyl residues, and therefore do not appear in the msps.

In
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Figure 26. Two-dimensional tryptic peptide maps of the gp90 component
from five EIAV isolates. Arrows and open circles indicate peptide
additions and deletions, respectively, observed when each isolate is
compared to its Immediate predecessor.
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Figure 27. Two-dimensional glycopeptide maps of the gp90 component
from five EIAV isolates. Roman numerals in the upper left corner of each
pattern refer to the classes described in Table V III, page 109.
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addition, the glycopeptide patterns for gp90 from these two isolates are
strikingly different, which again stresses the importance of glycosylation
pattern differences in variation. Thus, although the peptide patterns
obtained for gp90 from these two isolates are the same, there is still
structural variation between the two molecules.
The glycopeptide patterns for the gpQO component from these five
isolates again showed some repeated patterns (Figure 27 ), as was 3 een in
the four previous isolates studied. Isolates P3.2-1 and P3.2-4 exhibited a
similar pattern, which is also the same glycopeptide pattern seen for
prototype gp90. Isolate P3.2-2 exhibited a pattern seen before in isolates
P 3.1-1, P 3 .1-2, and P 3 .1-4, while isolates P3.2-3 and P3.2-5 shared a
glycopeptide pattern not yet seen In any other Isolates. It Is Interesting
to note that the three isolates recovered over the shortest time period
from the same animal all exhibit different gp90 glycopeptide patterns,
even though two of the three gp90 peptide patterns were the same.
In constrast to the gp90 peptide patterns, no two identical peptide
patterns were seen for the gp45 component from these five isolates
(Figure 2 8 ). Peptide additions and deletions were observed between each
pair of successive isolates examined, including P3.2-2 and P 3.2-3. In
contrast, the respective gp45 glycopeptide maps were completely
identical for each of these five isolates (Figure 2 9 ). It therefore appears
that while comparable variation occurs in the peptide portion of the gp90
and gp45 components, more variation is seen in gp90 glycopeptide
patterns than in the corresponding patterns of gp45.
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Fig ure 2 8 .

Two-dimensional tryptic peptide maps of the gp45 component

from five EIAV isolates. Arrows and open circles indicate peptide
additions and deletions, respectively, observed when each isolate is
compared to its immediate predecessor.
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P3.2-2:

P3.2-1

%

P3.2-3

I

P3.2-4I

*

P3.2-5

Figure 2 9 . Two-dimensional glycopeptide maps of the gp45 component
from five EiAV isolates.
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The internal EIAV polypeptides p26, pt5f and p9 from the five isolates
were also analyzed by two-dimensional tryptic peptide mapping (Figure
30, panels A, B, and C, respectively). The patterns obtained for p26
from all five Isolates were Identical to each other, and also Identical to *
the patterns obtained for this polypeptide from all previous strains,
including the prototype virus. The same results were observed for both
p i5 and p9. Thus it appears that structural variation in EIAV during either
horizontal transmission or persistent Infection 1s restricted to those
virion polypeptides which are subject to host immune selection
mechanisms (gp90 and gp45), and that no such structural variation
occurs in the internal virion polypeptides which are not recognized by the
host immune defenses during natural Infection.
Comparison of Ten EIAV Isolates
To determine the total number of structurally distinct EIAV strains
represented in the panel of variants, each isolate was judged on four
criteria — gp90 peptide pattern, gp90 glycosylatton pattern, gp45 peptide
pattern, and gp45 glycosylation pattern. For any two isolates to be
considered as structurally 'identical-, all four structural criteria must
also be identical. In this way, variations in any one criteria is
interpreted to mean that the two isolates are structurally distinct.
To facilitate comparison of the peptide patterns obtained for the gp90
components of the ten EIAV isolates, schematic diagrams of the peptide
map for each isolate were compiled to yield a composite pattern of all
peptides observed In msps of this glycoprotein. In this composite map,

pta-a

P3.M;

P3.S-3

\„

P3.2-3

P3.3-3

, t

P3.J-4

f -!

'fesr;

Figure 30 . Two-dimensional tryptic peptide maps of the internal
polypeptides p26 ( A ) , pt5 (B), and p9 (C) from five EIAV Isolates.

P3.2-S
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shown in Figure 31 f peptides which are common to the gp90 component of
a ]l isolates are represented by filled symbols. The open symbols
represent those peptides in the gp90 patterns which vary between
Isolates. A ll peptides were assigned an arbitrary number for
identification, and a table was generated showing the distribution of the
varying peptides among the ten EIAV isolates (Table V I).
Of the 54 gp90 peptide3 considered in this comparison, 27 (or 50%)
were found to vary among the different EIAV Isolates. The distribution of
varying peptides was identical only for isolates P3.2-2 and P3.2-3, as was
mentioned previously. This pattern was not shared by any of the other
isolates, and no other isolates appeared to share identical patterns.
These ten EIAV strains thus exhibit 9 distinct gp90 peptide patterns.
Examination of peptide distribution revealed that structural variation in
gp90 is apparently not accomplished by the accumulation of peptide
changes. If such accumulation had occurred, a change observed in a
given isolate would be retained In subsequent Isolates. This phenomenon
is not observed, as demonstrated by numerous peptides. For example,
peptides #28, #33, and #44 are present in P 3 .1-1 gp90, but is absent in
P 3 .1-2. These peptides are again present in P 3 .1-3 gp90, but are not
observed In the P 3 .1-4 pattern. Thus it appears that structural variation
in gp90 is accomplished by the alternate presence or absence of peptide
changes in a specific pattern.
Comparisons of isolates recovered from a single animal reveal fewer
peptide differences than do comparisons of isolates recovered from

Figure 3 1 .

Composite two-dimensional tryptic peptide map of gpQO,

containing all peptides seen in ten EIAV strains. Arbitrary numbers were
assigned to each peptide for identification.
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Table VI- Distribution of unique peptides in the two-dimensional patterns
obtained for the gp9Q component from ten EIAV strains. A (+ ) or ( - )
indicates the presence or absence, respectively, of a peptide 1n a given
isolate.
peptide prototype P3.1-1 P3.1-2 P3.1-3 P3.1-4 P32-1 P3.2-2 P32-3 P3J2-4 P32-5
7

+

+

+

+

+

-

12

-

-

+

-

+

15

-

+

+

+

18

-

-

-

20

+

-

21

-

25

♦

-

+

-

+

+

-

-

-

-

-

-

-

+

-

-

-

-

-

-

+

-

-

28

+

+

-

+

-

+

+

+

+

+

29

-

+

+

+

+

•k

+

+

+

+

+

+

+

+

+
+

30

+

+

33

+

+

35

-

+

+

36

+

+

38
39

-

40

-

43

-

44

+

45

+

+

♦
-

+

+

-

+

+

+

♦

-

-

+

-

+

-

+

+

46

+

47

+

+

+

+
-

-

+

-

+

-

+

+

+

+

+

+

+

+
-

+
+

+

-f

+

-

+

+

+

+

+

-

+

+

+

+

+

-

+

+

+

+

+

-

+

+

+

*

+

+

+

+

+

+

-

+

+

+

+

+

+

+

+

+

+

+

+

+

48
49

+

-

+

-

50

+

-

+

-

51

+

+

+

-

+

52

+

+

-

+

-

53

+

+

-

+

-

+

+

+

+

+

+

+

+

+

+

+

-

+

+
-

+
+

+

+

+

+

+

+

+

-

+

+

+

+

+

+
+

+
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different animals. In fact, one peptide (#20) was present in all five P3.2
isolates, but was absent in all four P 3 .1 Isolates. This may reflect
structural changes in gp90 associated with adaptation of EIAV to
replication within a single individual.
A similar composite pattern was constructed for the gp45 maps from
the ten EIAV Isolates (Figure 3 2 ). Of the 46 different peptides considered
in the comparison, only 12 of these, or 26%, appeared in all ten isolates
(Table V II). It is not possible to infer from this data that more structural
variation occurs in gp45, since the proportion of peptides detected by this
mapping procedure as compared to total peptides has not been
determined. Of the ten isolates examined, no two exhibited identical gp45
peptide patterns. Therefore, this panel represents ten structurally
distinct EiAV strains. As was demonstrated for gp90, it appears that
structural distinction in gp45 occurs by the presence or absence of
peptide changes, and not by accumulation of such changes.
Comparison of the glycopeptide maps for the gp90 and gp45 components
of these isolates was simpler than for the peptide maps, since patterns
were repeated among Isolates. Table VMI shows a possible classification
scheme for these patterns. Four different patterns were seen in the gp90
glycopeptide maps, given as Class I through IV. The most common
appears to be Class II, which is exhibited by four isolates. The pattern
exhibited by isolate P 3 .1 -3 1s unique, and not seen 1n any other Isolate. In
contrast, there are only two glycopeptide patterns seen for the gp45
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Table V II. Distribution of unique peptides in the two-dimensional
patterns obtained for the gp45 component from ten EIAV isolates. A (+) or
( - ) indicates the presence or absence, respectively, of a peptide In a
given isolate.

peptide prototype P3.1-1 P3.1-2 P3.1-3 P3.1-4 P32-1 P32-2 P32-3 P32-4 P32-5
2
3
6
10
11
12
14
15
17
10
19
20
21
22
23
24
25
26
27
29
30
31
33
35
36
38
39
40
41
42
43
44
43
46

-

4

4

4

4

-

4

4

-

4

4

4

-

4

4

-

-

-

4
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-
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-
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4
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-
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-
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4
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4
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-
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-
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-
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4

-

-

-
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4

-

4

4

4

4

4

-

4

4

4

4

-

-

4

-

4

-

4

4

4

4

4

-

4

4

4
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4
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4

4

4

4

-
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-

-

-
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4
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-
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-
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4

-

4

-

4

-

4

4

4

4
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-

4

4

-

4

4

4

4

-

4

4

4

-

-

-

4

m

-

-

4
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Table V III. Classification of EIAV isolates by glycopeptide patterns of
the gp90 and gp45 components.

A. Classification by gp90 glycopeptide patterns.
Class 1

Class II

Class III

Class IV

prototype
P3.2-1
P3.2-4

P3.1-1
P 3 .1-2
P 3 .1-4
P3.2-2

P 3 .1-3
P3.2-5

P3.2-3

B. Classification by gp45 glycopeptide patterns.
Class 1
prototype
P3.1-1
P 3 .1-3
P3.2-1 thru P3.2-5

Class II
P 3 .1-2
P 3 .1-4
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component, the first of which seems to be heavily favored. This data may
indicate that while glycosylation differences in gp90 occur readily the
glycosylation pattern of gp45 may be important to structure or function
and therefore must remain rather constant.
This comparison of isolates recovered from parallel experimental
infections reveraled that no two isolates, regardless of origin, were
structurally identical. Both animals received the same inoculum, but
parallel peptide or glycopeptide patterns were not observed. Thus the
evolution of variation in EIAV in the two infections occurred with no
evidence of a predictable pattern. This may reflect a very large number
of possible variations in EIAV.
III. SEQUENCE OF THE EIAV env GENE — COMPUTER MODELING OF od90 AND
OP45

Recently, the entire envelope gene sequence for prototype EIAV was
determined for a cloned proviral segment recovered from the DNA of
persistently infected fetal equine kidney cells (Rushlow et al. 1986). This
DNA sequence was then "translated" by computer into the predicted amino
acid sequence for the entire envelope polyprotein. Proteolytic processing
sites for the production of gp90 and gp45 were tentatively located, as well
as all possible N-linked glycosylation sites. The "processed" amino acid
sequences for the gp90 and gp45 polypeptides were then analyzed by
several predictive computer programs, and a possible structural
conformation was predicted for these two EIAV glycoproteins.

Ill

Analysis of the envelope

D o lv p ro te .in _ s e q u e n c e

The entire amino acid sequence for the envelope polyprotein of EIAV is
given in Figure 33, and is derived from the proviral DNA sequence
determined previously (Rushlow et a l . , 1986). The amino terminus of the
predicted polyprotein contains a region of 21 hydrophobic or uncharged
residues, which precedes a region of charged residues (E-K-S-K-C-E-E).
These properties are consistant with a signal sequence (Perlman and
Halvorsen, 1983), which is removed by proteolytic cleavage to produce a
gp90 amino terminus of glutamate. Recent end group analysis of purified
gp90 from prototype EIAV indicates a probable amino terminal residue of
glutamate or glutamine, which supports this prediction (V. Rao and J.
Ball, unpublished results). The gp90 portion of the polyprotein extends
for 424 amino acids, ending with a conserved arginine-rich segment
(R-H-K-R). This segment is analogous to the cleavage sites reported for
most retrovirus envelope precursors (Seiki et a l., 1983; Herr et a l.,
1984; Sodroskf et a l . , 1984). Thus, the processed gp90 polypeptide
consists of residues 21 - 444, and the gp45 polypeptide consists of
residues 445 - 859.
Analysis of potential N-linked glycosylation sites revealed 13 such
N-X-S/T sites within gp90, snd 5 such sites in gp45. It is Interesting to
note that the glycosylation sites in gp90 are very evenly distributed
throughout the molecule, but all but one of these sites are found in the
N-terminal region of gp45.
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F ig ure 3 3 .

Amino acid sequence for the envelope polyprotein of

prototype EIAV. The signal sequence cleavage site (1 ) and precursor
cleavage (2 ) are indicated by arrows. Potential glycosylation sites are
indicated by diamonds.
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Prediction of transmembrane regions
According to the algorithm developed by Kyte and Doolittle (1982),
transmembrane regions can be predicted in amino acid sequences. For a
stretch to qualify as transmembrane, it must consist of at least 19
consecutive amino acids, and the average hydrophobicity over the entire
stretch must be greater than 1.6. To determine possible transmembrane
segments in gp90 and gp45, hydrophobicity plots were generated for these
sequences (Figures 34 and 3 5 ). Possible hydrophobic stretches of at
least 19 amino acids were located by visual analysis of the profiles, after
which the average hydrophobicity wss calculated for each possible
sequence.
Four such hydrophobic amino acid sequences exist in the profile
generated for gp45 (residues 446 - 465, 617 - 636, 787 - 806, and 816 834). The average hydrophobic value for these four sequences are 2.14,
2.17, 2.19, and 1.87, respectively, and therefore all four qualify as
possible transmembrane regions. No such possible sequences are
present in the profile for gp90, which exhibits an overall hydrophilic
character, it appears from this analysis that gp90 itself has no
association with the lipid membrane surrounding the virus, and must
therefore be attached by interaction with gp45. This interaction has been
proven previously to nfil involve disulfide linkages between the two
glycoproteins (Parekh et a l., 1980).
Prediction of antioenic sites
It has been postulated by Hopp and Woods (1981) that possible
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Fig ure 3 4 .

Hydropathic character of the predicted gp9Q polypeptide

sequence. Hydrophobic character is represented as positive, and
hydrophilic character is represented as negative. Numbering is the same
as in Figure 33.
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Fig ure 3 5 .

Hydropathic character of the predicted gp45 polypeptide

sequence. Hydrophobic character is represented as positive, and
hydrophilic character is represented as negative. Numbering is the same
as in Figure 33.
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antigenic sites may coincide with predicted regions of hydrophilicity within
a polypeptide sequence. They found that the region of highest hydrophilic
character coincided with a proven antigenic site in a large number of
proteins examined. In addition, other hydrophilic regions may or may not
be antigenic because of their probable position at the surface of the
protein.
The highest region of hydrophilic character in gp90 is located between
residues 5 7 - 7 1 , with a peak at residue 66 (Figure 3 4 ). There are no
possible glycosylation sites within this region, indicating that the peptide
backbone is not masked by carbohydrate. Other hydrophilic regions exist
at numerous positions along the sequence, and account for a large portion
of the gp90 polypeptide. Thus there Is a large number of possible epitopes
predicted by this method.
The major region of predicted hydrophilic character in gp45 occurs
between residues 691 - 721 (Figure 35) and may also represent an
antigenic site. However, since the exact orientation of gp45 in the lipid is
not known, this region may be exposed to the inside surface of the
membrane, and although antigenic may not be accessible to antibody
during natural infection.
Determination of secondary structure
The algorithms developed by Chou and Fasman (1974, 1978) for the
determination of secondary protein structure were employed as a final
analysis of the gp90 and gp45 polypeptide sequences. It must be
remembered that the reliability of these programs to assign correct
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F ig ure 3 6 .

Secondary structure of the gp90 polypeptide predicted by the

Chou and Fasman method (1974, 1978). A (-2) represents a residue in
helical structure, a

(a )

represents a residue 1n sheet structure, a (—)

represents a residue in random coil, chain reversals indicate turns, and
diamonds represent possible glycosylation sites. Numbering is the same
as in Figure 33.
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Figure 37 . Secondary structure of the gp45 polypeptide predicted by the
Chou and Fasman method (1974, 1978). A (A) represents a residue in
helical structure, a

(a )

represents a residue 1n sheet structure, a (—)

represents a residue in random coil, chain reversals indicate turns, and
diamonds represent possible glycosylation sites. Numbering is the same
as in Figure 33.
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conformation to a given residue is in the range of 5* to 70* accuracy, and
any structure based on this analysis can only be considered an
approximation.
The predicted structures for gp90 and gp45 are given in Figures 36 and
37, respectively. The gp90 polypeptide is predicted to consist of 24*
or-helix and 22* 0-sheet structure, which is consistant with a compact,
globular conformation (Chou and Fasman, 1974, 1978). The or-helix
content of gp45 is comparable to that of gp90, at 23*. There Is a slightly
higher 0-sheet content predicted for gp45 (3 0 *), which may indicate that
gp45 is more structurally constrained than gp90 due to greater intrachain
hydrogen bonding. However, the nature of the interaction between gp90
and gp45 is not obvious from these predicted structures. Therefore very
important nuances in the specific protein folding of gp90 and gp45 may be
overlooked in a direct interpretation of the predicted structures.

CHAPTER 4
DISCUSSION

The experiments described in these investigations have enabled us to
determine the following:
1) An approximate minimum time span required for the emergence of
novel antigenic and structural variants of E1AV during persistent infection
in a single animal.
2) The contribution of the various EiAV polypeptide components to
antigenic and structural variation during persistent infection in the same
animal.
3) An estimation of the minimum number of possible distinct EIAV
variants and their pattern of evolution.
4) The hydropathic character and general conformation of the EIAV
surface antigens gp90 and gp45.
Previous investigations into antigenic and structural variation in EIAV
involved several isolates recovered during the first and last disease
episodes from three experimentally infected animals (Montelaro et a l . ,
1984a). These isolates were distinguished antigenically in neutralization
assays using autologous antisera and were shown to exhibit structural
changes in the peptide portion of the major surface antigen, gp90, as
indicated by two-dimensional tryptic peptide mapping. This was the first
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experimental evidence to support the hypothesis of antigenic variation as a
mechanism for EIAV persistence since its proposal 11 years previously
(K o n o e ta l., 1973).
Since EIAV isolates recovered from the same animal in these studies '
were separated by up to 6 .5 months and as many as four intervening
disease episodes, no minimum estimate of the time required for the
emergence of novel antigenic and structrual variants could be
determined. In addition, no structural analysis of the gp45 surface
antigen from these isolates was possible due to high background in the
mapping technique, snd techniques for the analysis of the carbohydrate
moieties of these glycoproteins had not yet been developed.
In the present Investigations, nine EIAV isolates recovered from
sequential disease episodes in two ponies infected in parallel with the
same plasma inoculum (Figure 24) were examined in both serological and
structural analyses, as was the prototype strain. All four isolates from
one animal (P3.1-1 through P 3.1-4) could be antigentcally distinguished
by neutralization assays employing antisera collected from the ssme
animal between disease episodes (Salinovich et a l . , 1986), indicating that
distinct antigenic variants are associated with each clinical episode. In
addition, these same four isolates could be distinguished antigenically by
reactivity of their gp90 glycoprotein component in immunoblot analyses
with a panel of gp90-specific monoclonal antibodies. In contrast, all
gp45-specific monoclonal antibodies tested reacted with this component
from all nine EIAV strains, as well as the prototype virus. These results
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may indicate that although gp45 is strongly recognized by the host during
infection, this glycoprotein does not contribute greatly to observed
antigenic variation in EIAV. The gp90 component thus appears to be
responsible for both induction of neutralizing antibody 1n the host, as well
as the generation of antigenic variants. Further studies with a broader
panel of monoclonal antibodies is necessary before the relative
contribution of these two glycoproteins to antigenic variation in EIAV can
be accurately assessed.
No neutralization data was available for the five isolates from the
second animal (P 3 .2 -! through P 3 .2 -5 ), and antigenic distinction by
reactivity with glycoprotein-specific monoclonal antibodies was hampered
by the small number of antibodies available. However, two of these
isolates, P3.2-2 and P3.2-5, could be distinguished from each other and
from all remaining P 3 .1 and P3.2 isolates on the basis of the reactivity of
their respective gp90 components in immunoblot analysis with specific
monoclonal antibodies. Even though the analysts was admittedly limited,
it appears that this panel often EIAV isolates represents at least seven
antigenic variants. These results indicate that antigenic variation can
occur in EIAV isolates recovered from disease episodes separated by only
17 days (the time span between recovery of isolates P3.2-1 and P 3 .2 -2 ),
and that this variation is determined predominantly by changes in specific
epitopes of the gp90 molecule. Thus, the time frame required for
antigenic variation in EIAV is considerably shorter than that reported for
visna virus, which requires one to two years for the emergence of
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antigenic variants in the persistently infected animal (Scott et a l . , 1979;
Clements et a l . , 1980),
Two-dimensional tryptic peptide mapping of the major polypeptide
components from these ten EIAV strains was facilitated by the use of
discontinuous SDS-PAGE (Laemmli 1970) for their separation and isolation
prior to mapping. In this gel system, the gp90 component could be
completely separated from a closely-migrating cellular glycoprotein,
therefore decreasing the possibility of contamination in the subsequent
peptide analysis. It was also possible to obtain gp45 in a pure form from
this gel system, thus allowing its analysis for the first time.
As demonstrated in Table VII, no two isolates studied exhibited
Identical gp45 peptide patterns, regardless of origin. Similar results
were observed for the gp90 peptide patterns, with the notable exception of
isolates P3.2-2 and P3.2-3, which exhibited identical patterns. Although
these ten isolates apparently represent only 7 antioenicallv distinct
classes, all are structurally distinct by virtue of their surface
glycoproteins. Thus, structural variation in the surface glycoproteins of
EIAV during persistent infection can apparently occur as rapidly as
antigenic variation.
The structural variation seen In the gp90 and gp45 peptide maps
appeared to be much greater when comparing isolates recovered from
different animals than when comparing isolates recovered from the same
animal. It is also interesting to note that although both animals in this
study received the Identical virus inoculum, the EIAV variants associated
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with the first disease episode in each animal (isolates P 3.1-1 and P 3.2-1)
exhibited very different gp90 and gp45 peptide patterns. This may
represent structural changes necessary for adaptation to replication in
the two different animals. Structural variation in the gp90 polypeptide
has been previously demonstrated upon horizontal passage of the virus in
animals (Montelaro et a l . , 1984a), thus paralleling the results obtained
here.
Similar two-dimensional tryptic peptide analysis of the Internal
nonglycosylated polypeptides p26, p i5, and p9 demonstrated that no
detectable structural variation had occurred in any of the EIAV isolates
examined, it had previously been reported that structural variation
occurred in the p26 component of EIAV Isolates concurrently with the
return of virulence after prolonged passage of the virus in tissue culture
(Montelaro et a l . , 1984a). This variation was shown to be due to
concurrent mapping of p26 and a cellular contaminant which comigrate in
the SDS-PAGE system used to separate viral components in the original
study. The use of the discontinuous SDS-PAGE system in the present
studies allowed for the separation of these two polypeptides such that p26
could be obtained in pure form for peptide analysis. Thus none of the
internal polypeptides of EIAV examined contribute to structural variation
in EIAV.
With the development of modifications to the peptide mapping
procedure, glycosylated peptides of gp90 and gp45 could finally be
analyzed (Salinovich and Montelaro, 1986). Such analysis of the
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carbohydrate moiety has not been previously possible, since conventional
techniques require relatively large quantities of pure substrate, which
are not available for either of the EIAV surface glycoproteins. In
addition, analysis of carbohydrate by successive cycles of specific
glycosidase digestion and gel filtration analysis, although very useful in
some situations, offers relatively low resolution and gives no information
as to the point of attachment (Hunt and Wright, 1981, 1983). The
glycopeptlde mapping technique developed here was capable of resolving
glycosylated peptides such that a distinctive 'fingerprint* could be
generated, in which the peptide to which the carbohydrate is attached also
contributes to the final pattern obtained. Such minor changes as removal
of sialic acid residues could also be readily detected. Glycopeptlde
fingerprints from the gp90 and gp45 components of the nine isolates were
thus generated and compared to determine possible variations in
glycosylation.
In contrast to the peptide patterns, identical glycopeptlde patterns
were observed for the gp90 and gp45 components from several of the
isolates. Four possible glycopeptide patterns were exhibited by gp90, and
only two patterns by gp45. It is interesting to note that changes in
glycosylation do not occur often in gp45, and that this glycoprotein also
does not appear to contribute greatly to EIAV antigenic variation.
However, glycosylation patterns appear to be very important in antigenic
variation in gp9Q. Isolates P 3 .2 - I, P3.2-2, and P3.2-3 were recovered
from the same animal only 17 and 26 days apart, respectively, and the
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three gp90 components from these isolates exhibited distinct glycosylation
patterns. The importance of this carbohydrate contribution is increased
by the fact that two of these three isolates (P3.2-2 and P3.2-3) exhibited
identical gp90 peptide patterns. These two latter Isolates were shown to
be antigenically distinct by virtue of their reactivity with gp90-specific
monoclonal antibodies. These observations are consistent with the
findings of Alexander and Elder (1985), which demonstrated the
importance of glycosylation to the antigenic characteristics of viral
glycoproteins. In these studies, antibodies raised against intact Rauscher
murine leukemia virus (R-MuLV) gp70 were generally directed toward the
carbohydrate of this antigen. Binding avidity of these antibodies to intact
gp70 was lower than that observed for corresponding antibodies generated
against the gp70 polypeptide backbone. Thus glycosylation may
effectively ’ mask’ highly antigenic sites along the peptide structure,
leaving the immune system of the host to produce low avidity antibodies to
the glycoprotein antigens of the infecting virus. This may well be the case
in EIAV, where at least 10% to 15% of the host's immune response to gp90
during natural infection is directed toward the carbohydrate (Montelaro et
a l., 1984a). In addition, virus neutralizing antibodies in the naturally
Infected animal are of relatively low titers (Orrego et a l., 1982).
It is highly unlikely that the observed peptide and glycopeptlde changes
are due to artifacts of the mapping procedure. Three to five patterns
were generated for the gp90 and gp45 components from each isolate, and
the observed peptide alterations were completely reproducible. The
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possibility of contamination is rather small, since concurrent analysis of
two or more 90,000 or 45,000 da proteins would result in a very large
number of peptide alterations, all of which would be additions. Also, the
fact that two isolates exhibited identical gp90 patterns argues strongly

*

against the presence of contamination. A ll virus strains were cloned by
limiting dilution prior to propagation in tissue culture and subsequent
biochemical analysis, so the possibility of mapping the gp90 or gp45
component from two or more strains concurrently was minimized.
It should be emphasized that the peptide and glycopeptide mapping
procedures used here provide only a minimum estimate of the total
structural variation possible in EIAV. Only those fragments which contain
tyrosyl or histidyl residues susceptible to radloiodination are detected.
Thus the actual level of structural variation is probably much greater,
and can only be quantited by determining the amino acid sequences of the
glycoproteins from these isolates.
The fact that peptide and glycopeptlde alterations were observed in
isolates recovered only 17 days apart from the same animal, but no such
alterations were observed after replication of the virus in tissue culture
for up to six months, suggests that immune selection pressures, absent in
tissue culture but prominent in the natural host, play a significant role In
the emergence of antigenic and structural EIAV variants during persistent
infection. In support of this hypothesis is the lack of detectable variation
in the internal EIAV polypeptides, which are protected from the host's
immune defenses in the intact virion. Any structural changes in these
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internal polypeptides arising from mutations thus offers no special growth
advantage and therefore are not selected by immune pressures.
These observations raise the question of the origin of structural
variation in EIAV glycoprotein antigens. Payne et al. (1984)
demonstrated that the genomes of EIAV isolates recovered months apart
from different experimentally infected animals exhibited altered RNase
Tj-resistent oligonucleotide patterns, and that the number of observed
alterations was conslstant with the occurrance of point mutations in the
respective EIAV genomes. Recently, the genomes of EIAV isolates P 3 .1-1
through P 3 .1-4 were also analyzed by this procedure (Salinovich et a l.,
1986), and the results showed that genomic alterations occurred
concurrently with structural and antigenic variation in the surface
glycoproteins, in fact, most of the altered oligonucleotides present in
isolate P 3 .1-3 could be localized to the 3' region of the genome,
corresponding to the env gene which codes for the gp90 and gp45
components, it is unlikely that recombinational events were responsible
for the observed oligonucleotide alterations, since endogenous
ElAV-related sequences with which recombination could occur have not
been found in normal horse DNA or the DNA of other members of the genus
Equus (Rice et a l., 1978). Also, one would expect a high number of
oligonucleotide alterations in the event of recombination, which was not
observed in these experiments.
Similar studies have demonstrated the occurrance of point mutations in
the genomes of antigenic variants of visna virus, and these alterations
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have also been localized to the 3' end, or env region, of the viral genome
(Clements et a l., 1980). In addition, sequence analysis of several
isolates of HTLV-III/LAV have demonstrated the presence of variation,
which appears to be concentrated in the env gene, and these alterations
are again consistent with the occurrance of point mutations and not
recombinational events (Sanchez-Pescador et a l . , 1985; Ratner et a l . ,
1985; Wain-Hobson et a l . , 1985). Thus it appears that variation in the env
gene products Is characteristic of members of the lentivirus subfamily.
The genomic and peptide alterations observed in antigenic variants of
visna virus recovered from the same animal were found to be cumulative,
such that all previous alterations were exhibited by a given isolate. The
structural changes observed in the nine EIAV Isolates studied here were
not cumulative, but appeared to originate from the expression of a
specific subset of possible variations (Payne et a l . , 1984; Salinovich et
a l., 1986). This was characterized by the presence or absense of
specific peptides in the two-dimensional tryptic maps of gp90 and gp45, or
RNase Tpresistant oligonucleotides in maps of the respective genomes.
These results may indicate the presence of mutational 'hot spots' in the
EIAV genome, which are localized to the env gene coding for gp90 and
gp45. Such regions have been located In the gene coding for the
hemagglutinin for type C influenza viruses, which also exhibit
noncumulative variation (Buonagurio et a l., 1985). Thus the mechanisms
by which variation is introduced into EIAV and visna virus may be
different.
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, From these results, a possible sequence of events can be visualized
for the emergence of antigenic and structural variants of EIAV during
persistent infection. Upon initial infection, the virus integrates into the
host genome and begins active replication, Indicated by the high plasma
viremia observed during the first 15 to 40 days post infection (Issel and
Coggins, 1979; Orrego et a l . , 1982). During this viremia, the animal
mounts an apparently competent immune response to virus in the plasma.
Most of the virus 1s cleared from the animal, but there may be a minor
population of mutant viruses present, either arising during replication in
the initial viremia, or present in the original inoculum. Once the initial
viral species is eliminated, the animal remains apparently healthy until
one or more of the mutant variants can establish itself and replicate In
sufficient quantities to produce a second burst of viremia and
accompanying clinical symptoms. These mutants, since not cleared by
the initial immune response, are not neutralized, and the animal must
mount a separate response against the new variant(s).
There are several factors which may contribute to the recurring
nature of EIA. The initial inoculum may well contain a mixture of virus
variants which can replicate equally well in the infected animal.
However, It Is logical to assume that all variants contributing to the fnitial
acute disease episode will be eliminated by the host's immune defenses.
The fact that the original inoculum may contain a mixture of variants again
emphasizes that EIAV is a highly mutable virus. In addition, there exists
no precedent for a virus system In which minor variant populations are
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sequentially selected by immune responses.
Another factor in the recurrance of EIA is possible host restriction of
EIAV replication, similar to that documented in visna virus. This virus
initially infects monocytes and other macrophage precursors, which are
not permissive to virus replication. However, upon maturity of
monocytes to macrophages, this restiction is eliminated and the virus is
able to replicate and induce disease (Gendelman et a l . , 1985). This
sequestering of visna virus 1n monocytes effectively prevents detection of
the virus by host immunosurveillance mechanisms. A similar mechanism
of host restriction may also be present in EIAV, which has been shown to
also replicate within monocytes and macrophages (McGuire et a l . , 1971;
llshlmi et a l., 1972). Unfortunately, very little Is known about the
molecular events of replication of EIAV in the natural host, and insight
into this aspect EIAV variation awaits such information.
Once the predominant virus variant associated with the initial burst of
viremia Is eliminated, there may be some very low levels of replication of
the integrated provirus even under restrictive host conditions. Mutations
may be introduced into the genome of the replicating virus, and a viable
antigenic variant may result. Once the restriction to replication is lifted,
the new variant is not recognized by the neutralizing antibody raised
against the initial variant and can therefore replicate in levels high enough
to produce a new cycle of disease. The high variability of frequency of
disease episodes seen in both natural and experimental infections could
arise from the varying probabilities that a given mutation will give rise to
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an antigenic variant that is not only capable of escaping neutralization by
existing antibody but is also replication competent and infective.
Whatever the mechanism, it appears that E1AV is a highly mutable
virus. However, only a limited number of structural changes are allowed
to occur in the glycoproteins to produce antigenic variants before function
is impaired and virus viability is lost, such that a finite number of total
serotypes of EIAV can exist. The ten EIAV strains included in the present
studies have been shown to represent at least seven different antigenic
strains, and the fact that these isolates were all shown to structurally
distinct increases the possibility that each is in actuality an antigenic
variant (Salinovich et at. , 1986). No pattern of predicatable evolution of
EIAV could be determined from examination of Isolates from two parallel
infections, suggesting a large number of variants. Thus, EIAV may
resemble the rhinoviruses, which have been shown to exist in over 120
distinct 3erotypes (Cooper et a l., 1978).
To aid in the production of effective vaccine protocols for the control
of EIA, the amino acid sequence of the envelope polyprotein, as predicted
from the nucleic acid sequence of a proviral segment from prototype
EIAV, was subjected to several types of computer modeling analyses.
These Included location of proteolytic processing sites and possible
N-linked glycosylation sites, determination of hydropathic character
(Kyte and Doolittle, 1982), and prediction of secondary structure (Chou
and Fasman, 1974, 1978). The entire envelope precursor consisted of
859 amino acids (Rushlow et a l., 1986), the first 20 amino acids of which
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represent a classic signal sequence for membrane-associated
glycoproteins (Perlman and Halvorsen, 1983). Amino acids 21 through
444 comprised the predicted gp90 amino acid sequence, which is
terminated by a four-residue proteolytic cleavage signal (R-H-K-R) for 9
the production of gp90 and gp45 from the polypeptide precursor. Residues
445 through 859 represent the gp45 amino acid sequence. Thirteen
possible glycosylation sites are evenly distributed throughout the gp90
sequence, which Is substantiated by previous work indicating that gp901s
rather heavily glycosylated (Parekh et a l . , 1980; Montelaro et a l . ,
1982). In contrast, only five such sites are observed in gp45, and four of
the five sites are clustered at the N-terminus of this molecule.
Hydropathfc analysis of these two polypeptides Indicates that gp90 has a
rather hydrophilic nature, while gp45 is relatively hydrophibic and is thus
probably associated with the lipid membrane of the virion. Prediction of
secondary structure (Chou and Fasman, 1974, 1978) indicates that gp90 is
globular in shape and may possess intricate folding, while gp45 appears to
be more restricted in conformation.
These results are very similar to those reported for the envelope
glycoproteins of both visna virus and HTLV-lli/LAV (Sonigo et a l . , 1985;
Sanchez-Pescador et a l . , 1985; Ratner et a l . , 1985). It has been shown
in both these viruses that the larger glycoprotein derived from the
N-terminus of the polyprotein is hydrophilic and globular, and is heavily
glycosylated along its entire length. The smaller glycoprotein derived
from the C-terminus of the polyprotein Is lightly glycosylated in the
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N-terminal region, and due to its hydrophobic nature, it is most probably
associated with the lipid bilayer.
From these considerations alone, there is no apparent association of
gp90 with the lipid envelope of the virus, such that some association must
exist between this glycoprotein and gp45 in the mature virion. It has been
previously shown that no disulfide bridges exist between these two
glycoproteins (Montelaro et a l., 1982). To investigate the nature of this
crucial interaction, the predicted secondary structures of both the gp9Q
and gp45 sequences were re-examined closely.
The regions consisting of residues 411 - 422, 440 - 444, 449 - 465, 471
- 482, and 518 - 530 all have high probabilities of being in either the
helical or sheet conformation (Table IX ). Of these regions, only residues
484 - 489 have a higher tendency to be in a sheet conformation; the rest
tend to be helical. A similar case is seen in the 29-residue peptide
hoarmone, glucagon. Residues 19-27 in glucagon are predicted by this
method to be helical, but the region also has a high tendency to be in a
sheet conformation (Chou and Fasman, 1978). It has been found that in
dilute solution, this region of glucagon is indeed helical. However, when
the concentration of glucagon is greatly increased, this region reforms
Into a sheet structure, which enters Into intermolecular hydrogen bonding
to the corresponding region of a second glucagon molecule (Chou and
Fasman, 1978). This reversion might also occur in the folding of the
mature gp90/gp45 complex.
As demonstrated in Figure 38, if all six regions of ambiguous
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Table IX . Relative probabilities of amino acid sequences to exist in
either a helix or sheet conformation. Probabilities for segments were
determined by averaging the individual amino acid probabilities over the
entire segment. Any values above 1.0 are considered strong
probabilities. <Pa > represents the probability of helical conformation,
and <Pp> represents the probability of sheet conformation.

PEPTIDE

<p«>

<Pp>

411 - 422 (gp90)

1.102

0.902

4 4 0 - 444 (gp90)

0.978

0.970

4 4 9 - 465 (gp45)

1.219

1.145

471 - 462 (gp45)

1.177

1.092

484 - 469 (gp45)

0.868

1.037

5 1 8 - 530 (gp45)

1.209

0.975
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Figure 38.

Possible structural interaction between the carboxy

terminus of gp90 and the amino terminus of gp45. (A ) Structure
predicted by strict application of the Chou-Fasman rules. (B) Structure
predicted if all ambiguous regions are assigned sheet conformation. A (4)
represents helix, a (A) represents sheet, a H

represents random coil,

chain reversals indicate turns, and diamonds represent glycosylation
sites.

Numbering is the same as in Figure 33.
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conformation are shown to be in a sheet structure, extensive hydrogen
bonding may form between the C-terminal region of gp90 and the
N-terminal region of gp45. In addition, possible glycosylation at residues
406, 411, 483, and 490 will mark this region as exposed to the surface of
the structure, thus allowing access of the protease to the polypeptide
cleavage site. For this hypothesis to be valid, the predicted
transmembrane segment from residues 446 to 465 in gp45 must actually
be involved in this sheet structure. The relative amounts of a-helix and
P-sheet predicted for either form of gp90 are not greatly distinct, making
experimental determination of actual structure difficult. However, the
difference in amounts of p-sheet predicted for the two forms of gp45 is
substantial enough (a change from 30X to 40£) to be distinguished
experimentally by circular dichroism.
Figure 39 shows a possible structure for both gp90 and gp45, which
includes placement in the membrane and Interaction of the two
glycoproteins. Note that 4 of the 5 possible glycosylation sites on the
gp45 molecule are exposed to the outside of the membrane, and the fifth
site is predicted not to be glycosylated. The gp45 molecule serves to
anchor the complex to the membrane, while the entire gp90 molecule Is
outside the membrane. The extensive sheet structure provides the
association necessary to retain gp90 in the mature virion. It should be
noted that any conditions which would destroy this hydrogen bonding would
release gp90 from the virion, which has been found experimentally to
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gp90

8P45

virion
exterior
lipid
bilayer

virion
interior

Figure 39 . Proposed structural domain model for the gp90/gp45
complex in mature EIA virions. Sheet structure and glycosylation sites
are indicated as in Figure 36.
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characteristic of this glycoprotein (Parekh et a l., 1980; Montelaro et a l.,
1982).
This model is consistent with observed characteristics of both gp90 and
gp45. By analogy with other retroviruses (Schafer and Bolognesi, 1977),
gp90 is important not only in host cell recognition but also in the induction
of neutralizing antibodies. This latter point is substantiated by the
results of the present study. According to this model, this component is
situated entirely outside the lipid membrane. The heavy glycosylation of
gp90 may mask highly antigenic sites on the peptide backbone, while
presenting the much less antigenic carbohydrate to the host's immune
system. Minor variations in peptide structure or especially in
glycosylation of gp90 would lead to possible antigenic variation in the
virus, which has also been demonstrated in the present studies. The fact
that very littte variation is observed in the gp45 glycopeptide patterns
may indicate that glycosylation is very important to virus viability. The
glycosylation of gp45, according to the model, apparently designates the
orientation of the gp90/gp45 complex in the membrane.
This predicted model for the gp90/gp45 complex provides a reference
point for the development of successful vaccination protocols for the
control of EIAV. Those regions of gp90 with high hydrophilic character
are likely targets for antibody production, since these regions are
probably exposed to the surface of the molecule (Hopp and Woods, 1981).
The importance of glycosylation to the antigenic reactivity of gp90 cannot
be overlooked, such that synthetic peptides used to induce possible
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neutralizing antibody must be glycosylated to the same extent as in the
native virus. Another possible target for antibody production may be the
region of interaction between the gp90 and gp45 molecules, since binding
of antibody to this region could conceivably cause a conformational change
resulting in the release of gp90 from the virion and subsequent loss of
infectivity.
However, a key determinant in the control of EIAV is the identification
of those cells or tissues In the host in which the virus is sequestered
during inapparent stages of the disease. Once this is elucidated, more
effective procedures for the control of this economically important
disease may be developed.
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APPENDIX I
LIST OF ABBREVIATIONS

AGID

Agar gel immunodiffusion

AIDS

Acquired immune deficiency syndrome

BSA

Bovine serum albumin

CAEV

Caprine arthritis encephalitis virus

DNA

Deoxyribonucleic acid

DOC

Deoxycholate

DPCC

Diphenyl carbamyl chloride

EDTA

Ethylene diamine tetraacetic acid

EIA

Equine infectious anemia

EIAV

Equine infectious anemia virus

FEK

Fetal equine kidney

FLV

Friend murine leukemia virus

HA

Hemagglutinin

HAT

Hypoxanthine/Aminopterine/Thymidine

HEPES

N"2-hydroxyethylp1perizine-N'-2-ethane suif 0n|C aci<j

HPLC

High pressure liquid chromatography

HTLV-I

Human T-cell leukemia virus type 1

HTLV-II

Human T-cell leukemia virus type II

HTLV-I II

Human T-cell lymphotropic virus type III

158

MEM

Minimal essential medium

PAGE

Polyacrylamide gel electrophoresis

POPOP

1,4-biS” [2-(-4-methyl-5-phenyloxazolyl)]-benzene

PPO

2,5-dtphenyloxazole

PPV

progressive pneumonia virus

RNA

ribonucleic acid

RSV

Rous sarcoma virus

TCA

Triclhoroacettc acid

TEMED

N,N,N',N'-tetramethylene diamine

TFA

Trifluoroacetic acid

Tris

tris (hydroxy methyl) aminoethane

APPENDIX II

Three-letter and one-letter designations for the 20 common amino acids.

Three-letter

One-letter

Alanine

Ala

A

Arginine

Arg

R

Asparagine

Asn

N

Aspartate

Asp

D

Cysteine

Cys

C

Glutamate

Glu

E

Glycine

Gly

G

Histidine

Hi a

H

Isoleucine

lie

1

Leucine

Leu

L

Lysine

Lys

K

Methionine

Met

M

Phenylalanine

Phe

F

Proline

Pro

P

Serine

Ser

S

Threonine

Thr

T

Tryptophan

Trp

W

Tyrosine

Tyr

Y

Valine

Val

V

Amino Acid
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APPENDIX I I I

Parameters assigned for computer modeling of the amino acid
sequence of the env gene.
A.

Hydropathic values assigned to the 20 common amino acid residues

for determination of hydrophobic and hydrophilic protein regions using the
algorithm of Kyte and Doolittle (1982).
Residue

Value

Residue

Value

Alanine

1.800

Leucine

3.800
-3.900

Arginine

-4 .5 0 0

Lysine

Asparagine

-3 .5 0 0

Methionine

1.900

Aspartate

-3.500

Phenylalanine

2.800

Cysteine

2.500

Proline

-1.600

Glutamate

-3 .5 0 0

Serine

-0.800

Glutamine

-3 .5 0 0

Threonine

-0.700

Glycine

-3 .5 0 0

Tryptophan

-0.900

Histidine

-3.200

Tyrosine

-1.300

Isoleucine

4.500

Valine

4.200

A positive value denotes a hydrophobic character, and a negative
character denotes a hydrophilic character.
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B. Conformational probabilities for the 20 amino acid residues for the
prediction o fa -h e lix andp-sheet by the methods of Chou andFasman
(1974,1978).

Residue

p«

Residue

PP

Ala

1.45 (1^)

0.97

Arg (+)

0.79 (ia )

Asn

P
roc

PP

Leu

1.34 (H*)

1.22 (hp)

0.90 (ip)

Lys (+ )

1.07 (la )

0.74 (bp)

0.73 (ba )

0.65 (bp)

Met

1.20 (ha )

1.67 (ty)

Asp ( - )

0.98 (la )

0.80 (ip)

Phe

1.12 (ha )

1.28 (hp)

Cys

0.77 Cia )

1.30 (hp)

Pro

0.59 (Ba )

0.62 (bp)

Glu ( - )

1.53 (H„)

0.26

(B p )

Ser

0.79 (ia )

1.20 (hp)

Gin

1.17 (ha )

1.23 (hp)

Thr

0.82 (ia )

1.20 (hp)

Gly

0.53 (Ba )

0.81 (ip)

Trp

1.14 (ha )

1.19 (hp)

His (+)

1.24 (ha )

0.71 (bp)

Tyr

0.61 (ba )

1.29 (hp)

Me

1.00 (fa )

1.60 (ty)

Val

1.14 (ha )

1.65 (ty)

(Ip )

Ha — strong « former

Hp — strong 8 former

ha — a former

hp — $ former

la — weak a former

Ip— weak p former

1a — indifferent a former

ip — Indifferent P former

ba — a breaker

bp — P breaker

Ba — strong « breaker

Bp - - strong P breaker

Pro and Asp are assigned la when at the N-terminus of a helix, and Arg is
assigned !a when at the C-terminus of a helix. Trp is assigned bp when at
the C-terminus of a sheet region.
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